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GENERAL INTRODUCTION 
Mycoplasma hyopneumoniae is tine etiological agent of mycoplasmal 
pneumonia of swine (MPS), one of the most important swine diseases all over the 
world (115). Although the mortality caused by MPS is usually low, the economic 
impact incurred by MPS is enormous because of retarded growth and poor feed 
conversion of infected pigs (116). Since the discovery of this mycoplasma in the 
1960s, MPS has been the focus for many research groups around the world. 
Accumulated information generated in the past decades has greatly improved our 
understanding of the pathogen and the disease. Commercial vaccines against 
MPS are now available. These vaccines significantly reduce the development of 
lung lesions in immunized pigs, but do not prevent infection with M. 
hyopneumoniae in the respiratory tract of swine (116). The fact that the virulence 
mechanisms of the organism have not been well defined is a limiting factor in 
development of highly efficient control measures for MPS. 
Previous in vivo studies with various immunohistochemical techniques 
demonstrated that M. hyopneumoniae cells polarized at the apical surface of the 
porcine respiratory tract epithelium during infection (4, 99, 140). This organism 
does not invade the epithelial cells nor penetrate the lamina propria. Colonization 
of M. hyopneumoniae in the respiratory tract leads to an extensive loss of cilia (15, 
140, 99, 156), which play an important role in the clearance of harmful substances 
and infectious agents. Therefore, M. hyopneumoniae infection not only induces 
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typical inflammation in tlie lungs, it also compromises tine defense system in the 
respiratory tract of pigs, which predisposes to secondary bacterial or viral 
infections. 
Adherence of M. hyopneumoniae to ciliated cells is an important initial step 
in the infection. Previous studies showed that this mycoplasma was able to adhere 
to many cell types in vitro (154, 157), although it only adheres to cilia of ciliated 
cells in vivo. Results from these in vitro studies suggest that the adherence process 
is a multiphasic and complex event, involving both nonspecific hydrophobic 
interactions and specific receptor-ligand interactions (157, 160). However, the strict 
tropism of the mycoplasmas for cilia as shown in vivo (99, 140, 156) and in a single 
ciliated cell adherence assay (160) strongly argue that receptor-ligand interactions 
are the major factor in the adherence of M. hyopneumoniae to ciliated cells. 
Partially due to the limitations in the established adherence assays and lack of 
monoclonal antibodies to the surface proteins of M. hyopneumoniae, previous work 
failed to define the molecular mechanisms involved in the adherence process. 
This project was designed to evaluate the receptors and adhesins that 
mediate the interaction of M. hyopneumoniae with ciliated cells. There were three 
specific goals for this study: 1) to establish a specific and convenient adherence 
model that mimics the in vivo attachment of M. hyopneumoniae] 2) to identify and 
characterize the natural receptors in cilia for M. hyopneumoniae adherence; and 3) 
to define the adhesins of M. hyopneumoniae. To achieve the first goal, cilia, which 
are the in vivo targets of W. hyopneumoniae infection, were purified from swine 
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tracheal ciliated cells and utilized to coat microtiter plates to develop a microtiter 
plate adherence assay. A number of glycoconjugates and carbohydrates were 
evaluated in this assay for inhibition of adherence of the mycoplasmas. For the 
second goal, a thin-layer chromatography (TLC) overlay assay was established to 
identify the glycolipid receptors in cilia for attachment of M. hyopneumoniae. In the 
third study, various immunochemical techniques along with the microtiter plate 
adherence assay were utilized to elucidate the adhesins of M. hyopneumoniae. 
Dissertation organization 
This dissertation contains a general introduction, literature review, three 
manuscripts, general discussion and references. The literature review precedes 
the first manuscript and a general discussion follows the last manuscript. 
References cited in a manuscript follows the manuscript, while literature cited in the 
general introduction, literature review, and general discussion is presented in a 
separate section which follows the general discussion. The three manuscripts were 
written in the style of Infection and Immunity. The investigations were planned 
and executed, and the manuscripts written, primarily by the Ph.D. candidate, Qijing 
Zhang, with the advice of the major professor. Dr. Richard F. Ross, and other co­
authors of the manuscripts. 
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LITERATURE REVIEW 
Adherence and its significance in bacterial infections 
Adherence, the process by which a microbe binds to tissue surfaces of man 
and animals, is a prerequisite for Initiation of infectious diseases (19). This is 
especially true for those microbial pathogens that colonize the mucosal surfaces. 
Bacterial adherence plays several important roles in infection (7, 19, 105): it 
confers on bacteria the ability to resist and circumvent the flushing and cleaning 
mechanisms that protect epithelial surfaces in humans and animals; it determines 
the tissue tropism of a pathogen; it delivers toxic effects on and induces signal 
transduction across host cell membranes; and it improves acquisition of nutrients 
from host cells. 
There is much evidence showing that adherence is directly involved in 
infection or pathogenicity. For many bacteria, such as salmonella, escherichia, 
streptococci, pseudomonas, staphylococci, and neisseria, their ability to adhere to 
target cells in vitro is well correlated with their infectivity in vivo (105). Satterwhite et 
ai. (122) reported that an isogeneic derivative of an enterotoxigenic strain of 
Escherichia co//(ETEC) which lacked adhering ability and colonizing factor, but 
retained the ability to produce enterotoxin, was unable to induce diarrhea in 
humans. In contrast, the parent strain possessing adherence ability produced the 
disease. This finding indicated that the bacteria must be able to adhere to the 
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intestinal epitlielial cells in order to multiply, colonize the mucosal surface and then 
produce sufficient amount of enterotoxin to cause diarrhea. In light of the 
susceptibility to E. co//infection, two phenotypes occur among swine populations. 
One has adhesive intestinal brush borders and is susceptible to K88+ ETEC 
diarrhea, and the other one has nonadhesive brush borders and is resistant to the 
disease (126). The difference between the phenotypes is genetically determined 
(43). The molecular basis for the difference was revealed by Erickson et al. (33) 
who demonstrated that the glycoprotein receptors for K88-mediated adherence are 
present only in the adhesive brush borders, but not in the nonadhesive brush 
borders. Older pigs gain resistance to diarrheal disease associated with E. coli 
bearing the K99 adhesin by loss of the receptors for the adhesin (117). Age-related 
expression of receptors is also responsible for susceptibility to infections caused by 
ETEC that do not produce K88, K99, F41, or 987P pill (104). The loss of adherence 
capacity caused by mutation leads to loss of the infectivity of Mycoplasma 
pneumoniae, and reversion of the adherent phenotypes is accompanied by 
regaining infectivity and virulence (79, 80). These findings strongly indicate that 
adherence is an important virulence factor of microbial pathogens. 
Bacterial adherence: molecular mechanisms 
The surfaces of bacteria and eucaryotic cells are overall negatively charged. 
How can adherence occur between two negatively charged surfaces? A widely 
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recognized theory for interaction between two negatively charged surfaces was 
provided by Derjaguin-Landau-Verwey-Overbeek (DLVO, 7, 19). According to the 
DLVO theory, when two objects with similar charges come into close approximation 
they are subjected to attractive and repulsive forces which vary with the distance of 
separation of the two objects. At long distances (>10 nm), the forces of attraction 
are greater than the repulsive forces, and the two objects are held in a state of 
mutual attraction. But the forces of attraction are weak at this stage, and adherence 
may be reversed. At short distances (<10 nm), the absorbed counter ion clouds on 
each surface cause the objects to repel each other. If the repulsive forces can be 
overcome and smaller distances (<1 nm) of separation achieved, then the forces of 
attraction are again greater than the repulsive forces, and the objects are held by 
firm binding. Bacteria must have specialized mechanisms to counteract the 
repulsive forces in order to achieve firm adherence. In fact, many pathogenic 
bacteria express adhesins that mediate adherence by recognizing receptors on the 
surface of eucaryotic cells. 
Adhesins, expressed on the surface of bacteria, are usually protein in 
nature. Many pathogenic bacteria, such as £ coli, Klebsiella pneumoniae, 
Salmonella typhimurium, Neissena gonorrhoeae, Pseudomonas aeruginosa, 
Bordetella pertussis, and Moraxella bovis, have fimbrial adhesins that are visible 
under an electron microscope (7, 69). Most fimbriae are proteinaceous polymers 
composed of major subunits, which have molecular weights ranging from 8,000 to 
26,000 daltons, and minor subunits. Recent findings have indicated that these 
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minor subunits are essential for structure and function of fimbriae (67). In fact, the 
adhesin subunits (receptor-binding domains) of many £ co//fimbriae are minor 
subunits distinct from the major subunits (52, 102). By using immunoelectron 
microscopy, the adhesin subunits of S, P, and type 1 fimbriae of E. co//were found 
to be located at the tips of the fimbriae or alongside the fimbriae as distinct globules 
(67,102,111,48). In contrast, the organization of the K88 fimbriae of swine 
pathogenic E. coli is different from the S, P, or type 1 fimbriae. The major subunit, 
rather than the minor subunit, of K88 fimbriae is the adhesin, indicating that it may 
be a polyvalent fimbriae (67). Besides fimbrial adhesins, E. coli also have 
nonfimbrial adhesins that are configured as very thin fibrillae surrounding the 
bacteria (66). 
Genes encoding the major and minor subunits of fimbriae are normally 
found clustered on the chromosome, together with genes encoding accessary 
proteins required for export and assembly of the fimbriae. Genetic studies indicate 
that the gene organization of nonfimbrial adhesins is similar to that of fimbrial 
adhesins, but lacks the gene encoding the major structural subunits for fimbriae 
(67). The expression of fimbriae is regulated by environmental conditions, for 
instance, temperature and growth rate (27). Phase variation between the fimbriated 
and nonfimbriated state has been observed with type 1 (1), 987P, and P fimbriae 
(27). Phase variation is also responsible for alternative expression of Q and I 
fimbriae of Moraxella bovis (98). 
A fine irregular fuzz, or fibrillae, which covers the streptococcal surface and 
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is composed of M protein and lipoteichoic acid (LTA), is responsible for adherence 
of streptococci to human epithelial cells (32). As an amphipathic surface molecule, 
LTA binds to many eucaryotic cells. A microorganism may have multiple adhesins, 
providing for increased adherence specificity and strength. N. gonorrhoeae has 
two adherence structures for tissue tropism (138). One is a fimbrial adhesin (pill), 
and the second is an outer membrane protein known as protein II (P II). 
Bordetella pertussis, a human pathogen that causes whooping cough, has 4 
potential adhesins: filamentous hemagglutinin (FHA), pertussis toxin (PT), 
pertactin, and fimbriae (147, 146, 88,151). FHA and PT adhesins mediate the 
interaction of B. pertussis not only with ciliated cells but also with human 
macrophages (147). FHA is a 220 kDa single polypeptide with a binding specificity 
to galactose-containing glycoconjugates on cilia. In addition, FHA has a Arg-Gly-
Asp (RGD) triplet which binds to the integrin receptor (CR3) on macrophages (146). 
PT is the only bacterial toxin known to have adhesive capabilities. Both FHA and 
PT can be cell-associated or secreted into the surrounding environment and are 
only expressed in virulent strains (146). Pertactin, a 69-kDa protein containing 2 
RGD sequences, appears to be involved in the adherence of B. pertussisXo 
macrophages. A B. pertussis mutant that does not express pertactin but does 
express other virulence associated proteins (FHA, PT, and fimbriae) adheres less 
well than the parent wild-type strains to mammalian cells (88). Fimbrial adhesins of 
B. pertussis have been characterized and isolated, but their role in adherence to 
human cells remains to be elucidated (151). 
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B. bronchiseptica, a pathogen that infects the upper respiratory tracts of pigs, 
dogs and rabbits, adheres specifically to nasal epithelial cells (153,13). This 
adherence appears to be mediated by fimbriae which are 3 to 4 nm in diameter 
and cross reactive with the fimbriae of B. pertussis (153, 87). Sialyl 
glycoconjugates are reported to be receptors for B. bronchiseptica in swine nasal 
epithelium (60). B. avium that colonizes the respiratory ciliated cells of turkey also 
has fine fimbriae which seem to be responsible for the adherence to tracheal 
epithelial cells (61). A recent study by Arp etai. (6) has shown that the receptors in 
turkey trachea for B. avium may be gangliosides or sialic acid-containing 
glycoconjugates. Belanger et al. (12) investigated the adherence of Actinobacillus 
pieuropneumoniae to porcine tracheal ring cultures. Their results suggested that 
lipopolysaccarides might be the adhesin of A. pieuropneumoniae. Although 
fimbriae have been found on A. pieuropneumoniae (148), their role in adherence 
remains to be determined. 
The animal cell surface is covered with a layer of carbohydrates associated 
with plasma membrane proteins or lipids. This is especially true for epithelial cells 
of mucosal surfaces (106). These surface components play an essential role in 
controlling many cellular activities, for Instance, development, differentiation and 
inter- or intracellular communication (106). Bacteria, bacterial toxins and viruses 
exploit these surface structures as attachment sites during infection (70). In most 
cases, the receptors on animal cells for microbial pathogens are glycoconjugate in 
nature. They can be either glycoproteins or glycolipids, in which the carbohydrate 
10 
moieties serve as receptor epitopes. Tine nature and the precise orientation of the 
carbohydrate moieties, as well as the neighboring molecular structures, determine 
the specificity of adhesin-receptor interactions and tissue tropism (70). In some 
cases, proteins, such as fibronectin, may serve as receptors for bacterial 
attachment, especially for Gram-positive bacteria and intracellular microbial 
pathogens (139). 
It is well known that different types of fimbriae of E. coli recognize distinct 
carbohydrate sequences. Type 1 fimbriae of E. co//bind specifically to mannose-
containing glycoconjugates. Mannosides inhibited type 1 fimbriae-mediated 
adherence and blocked infection of E. co//in the urinary tract (5). The P fimbrial 
adhesins of E. co//bind to the Gala1-4Galp residue of glycolipids, while the S 
fimbriae recognize the a-sialyl-(2-3)-p-Gal sequence (45). Sialic acid residues of 
glycoproteins or glycolipids (gangliosides) are common moieties for attachment of 
bacteria, viruses and mycoplasmas. Using monoclonal antibodies and various 
receptor analogues, Tuomanen et al. identified galactose or galactose-glucose-
containing glycoconjugates in human ciliated cells as receptors for adherence of B. 
pertussis (145). One of their interesting findings was that the receptors were only 
present on ciliary tufts, which are the in vivo sites for B. pertussis attachment, but 
not on cell bodies, indicating that the distribution of receptors for bacteria could be 
polarized in specific regions on host cell membranes. 
Development of a thin-layer chromatography (TLC) overlay assay has 
greatly facilitated the identification and characterization of glycolipid receptors for 
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microbes (49). In this assay, glycolipids separated on a TLC chromatogram are 
overlaid with bacteria, viruses, or toxins. Specific binding to a glycolipid receptor is 
detected by either immunological labels or radioactive labels. Combination of TLC 
overlay assay with modern analytical methodologies, such as mass spectrometry 
and nuclear magnetic resonance spectroscopy, results in resolution of the 
molecular structures of glycolipid receptors (71). The carbohydrate moieties of 
glycolipids are simpler in structure and closer to the membrane surface than those 
of glycoproteins. Therefore, bacteria bound to glycolipid receptors are intimately 
associated with the host cell surface. 
Most glycolipid receptors belong to three categories: gangliosides, sulfated 
glycolipids, and lacto-series glycolipids (85). Many pulmonary pathogens, such as 
Pseudomonas aeruginosa, Haemophilus influenzae, and Streptococcus 
pneumoniae, recognize the terminal or internal GalNAcp1-4Gaipi sequence found 
in gangliosides (84). This binding is independent of the sialic acid residues despite 
their presence in gangliosides. A recent study by Alphan et al. demonstrated that 
sialic acid-containing lactosylceramides on oropharyngeal epithelial cells and 
erythrocytes are responsible for the fimbriae-mediated binding of H. influenzae (3). 
It should be indicated that in many cases a carbohydrate sequence recognized by 
microbes is an internal sequence rather than a terminal sequence of 
oligosaccharides (84), implying that the accessibility of the sequence may affect the 
interaction with adhesins. Usually, sialic acid residues are located at the termini of 
oligosaccharide chains of glycoconjugates. Production of neuraminidase by some 
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bacteria during infection may play a role in unmasking tine internal sequence for 
binding. There may be a redundancy of receptors on eucaryotic cells 
corresponding to the existence of multiple adhesins of a microorganism. For 
example, Helicobacter pylori, a causative agent of chronic gastritis and gastric 
ulcers, binds specifically to three different receptors: sialylated glycoconjugates 
(34), sulfatides (121), and Lewisb antigens (17) on the surface of gastric epithelial 
cells. 
Integrins are a class of cell surface molecules with important physiological 
functions in cell-cell adhesion, cell-substratum adhesion, cell migration, cell 
differentiation, and signal transduction (31). Structurally, the integrins are 
transmembrane proteins consisting of a and p chains. Some bacteria utilize 
integrins as adherence receptors. One of the examples is B. pertussisXhaX utilizes 
the integrin as a port of entry to the intracellular compartment of macrophages 
(123). The invasion of macrophages is mediated by the interaction of FHA of B. 
pertussis and the integrin (CR3) on macrophages. Mutation of the Arg-Gly-Asp 
(RGD) sequence in FHA resulted in loss of the ability to enter macrophages, 
indicating that FHA has two different adhesin epitopes, one for ciliated cells and 
another for macrophages. The uptake of B. pertussis by macrophages did not result 
in bacterial killing, and therefore, provided a sequestered reservoir of bacteria 
within the macrophages. These findings suggest that the RGD-mediated 
adherence to the integrin on macrophages contributes to persistence of B. 
pertussis in human lungs. Another important finding in B. pertussis adherence is 
13 
that PT shares significant homologies in structure and function with the eucaryotic 
selectins, a family of glycoproteins that are expressed on the surface of endothelial 
cells and direct the movement of leukocytes (51,144). Usually, ligation of selectins 
with their corresponding ligands on leukocytes leads to increased expression of 
integrins on leukocytes. Based on the information, Tuomanen proposed that the 
adherence of B. pertussis could be a cooperative process in which secreted PT first 
interacts with macrophages and induces the expression of the integrin CR3, and 
then, FHA binds to CR3 resulting in entry to macrophages (144). Type 1-fimbriated 
E. coll has also been shown to utilize the GDI 1/CD18 integrin as a receptor for 
entry of phagocytes (38). Fibronectin and collagens are usually the receptors for 
Gram-positive bacteria such as Staphylococci and Streptococci (139). However, 
recent studies have indicated that some Gram-negative bacteria are also capable 
of binding to extracellular matrix proteins. Thus, the fimbriae of enterobacteria 
mediate adherence not only to epithelial cells by protein-carbohydrate interaction, 
but also to extracellular matrix by protein-protein interaction (66). It is believed that 
the two different interactions are mediated by different components of the fimbriae. 
For example, the adhesin subunit (35 kDa) in P fimbriae of E. coli is responsible for 
adherence to epithelial cells, whereas a distinct minor subunit (16.5 kDa) mediates 
the attachment of E. coliXo fibronectin and collagen; a 17 kDa subunit in the S 
fimbriae plays the same role as the 16.5 kDa subunit in the P fimbriae (66). This 
type of adherence may play a role in bacterial colonization of wounded tissues or 
in penetration of cells and tissues. 
14 
Adherence-mediated host response 
The adhesins of microbial pathogens not only play a role in tropism for 
tissues, but also induce host responses directly. For example, type 1 fimbriae of E. 
coli have been shown to stimulate T cell-independent proliferation of human B 
lymphocytes and secretion of immunoglobulins from resting B cells (107, 108). This 
stimulation is mediated by the mannose-specific adhesin subunit of type 1 fimbriae 
because a-methyl mannoside inhibits the response, and FimH- (without the 
adhesin subunit) type 1 fimbriae was nonstimulatory. Both in vitro and in vivo 
studies have shown that the P fimbriae of E. co//induce production of Interleukin 6 
by urinary epithelial cells, while the P fimbriae lacking the receptor-binding 
domains do not have the activity (91, 50). These findings indicate that the binding 
of carbohydrate receptors by the adhesins triggers cellular responses. It is 
reasonable to speculate that the adhesin-receptor interaction induces signal 
transduction across the cell membrane of epithelial cells, leading to expression of 
iL-6 molecules. Since IL-6 plays a role in inflammation by increasing the 
production of acute phase proteins and acting as endogenous pyrogen, it is 
possible that the fimbriae of £ coli are directly responsible for development of 
mucosal inflammation. These findings illustrate the newly discovered roles of 
fimbrial adhesins in the pathogenic mechanisms of bacteria. Considering the 
diversity of adhesin-receptor interactions, it is expected that more and more host 
tissue responses to microbial adhesins will be discovered in the future. 
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Enteropathogenic E. coli (EPEC) cause diarrhea in man and animals. 
Intestinal epithelial cells infected by EPEC exhibit an extensive loss of microvilli 
and a proliferation of filamentous actins beneath the regions of intimate bacterial 
attachment: this process is known as "attaching" and "effacing" (76). The 
mechanisms underlying the attaching and effacing process have been the focus for 
many research groups. Recent studies have suggested that adherence-induced 
signal transduction may play a role in microvillous effacing and rearrangement of 
cytoskeletal proteins (30). It was found that adherence of EPEC to eucaryotic cells 
leads to elevation of intracellular calcium; restoration of intracellular calcium levels 
prevented formation of attaching and effacing lesions, suggesting that second 
messengers are involved in lesion development (30, 9). Donnenberg and Kaper 
have speculated that elevated calcium concentrations lead to cleavage of actin 
within the microvillous core, resulting in effacement of microvilli (30). Adherence of 
EPEC to HEp-2 cells also results in phosphorylation of several cellular proteins, 
including myosin light chain, vaculin, a-actinin, and unidentified proteins (97, 112), 
which link the membrane receptors to cytoskeletal components. Inhibitors of 
tyrosine kinase blocked EPEC invasion (114). These observations strongly imply 
that protein phosphorylation and changes in intracellular calcium levels may be 
responsible for the ultrastructural lesions caused by EPEC infection. 
Adherence is essential not only for extracellular pathogens, but also for 
intracellular pathogens. In fact, adherence-mediated signal transduction is 
essential for many intracellular bacteria, such as shigella, yersinia, and salmonella. 
16 
to gain entry into mammalian cells (59, 16). For example, yersinia and salmonella 
encode an invasin which binds to the integrins or other membrane receptors on 
eucaryotic cells (16). This binding initiates a cascade of intracellular signals, 
leading to changed cell functions, especially those associated with the cytoskeletal 
networks, and uptake of bacteria. Many regulatory proteins, such as protein 
tyrosine kinases and MAP kinases, and intracellular messengers have been found 
to be involved in bacterial entry into host cells. 
Prevention of diseases by interfering witii adherence 
Because of the importance of adherence in bacterial infections, blockage of 
adherence should be a feasible approach to prevention of infectious diseases. One 
of the means is to immunize animals with vaccines prepared with purified 
adhesins. Vaccines prepared with purified fimbriae from various strains of E. coli 
have been successfully utilized to induce protective immunity against diarrhea in 
domestic animals. Rutter and Jones immunized pregnant sows with purified K88 
fimbriae and challenged the newborn piglets with the homologous strain of ETEC 
(119). Most of the piglets from immunized sows survived the challenge, whereas 
70% of the piglets from nonimmunized sows died of diarrhea, indicating that a 
protective passive immunity was induced by the fimbrial vaccine. A similar 
approach was applied to immunization of dams with K99, 987P, F41 or type 1 
fimbriae, and the antibodies to the fimbriae in the dams' colostrum protected 
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calves, lambs and piglets from subsequent challenges (2, 103,128, 118, 68). 
These vaccines depend on passive protection of suckling neonates via colostral 
antibody to fimbrial adhesins induced by vaccination of the dam during pregnancy. 
Although the protection is short-lived, it is practically useful because of the age 
specificity of ETEC infections. It is known that these fimbrial vaccines only induce a 
protective immunity to a homologous challenge; there is no cross protection 
between E. co//with different fimbriae. Multi-valent vaccines containing K88, K99, 
and 987P fimbriae provided additive protection against diarrhea of calves (22). 
These types of vaccines may be more useful than single-valence vaccines 
because of the existence of multiple fimbriated E. coli in natural infections. K88 and 
K99 vaccines have been produced by recombinant DNA technology (125). 
Vaccines consisting of CFA1, CS1, CS2, or CS3 fimbriae were also proven to 
protect humans from ETEC diarrhea (75). Experiments conducted in monkeys 
showed that immunization with P fimbriae offered protection against experimentally 
induced urinary tract infection caused by a P-fimbriated strain of E. coli, which 
causes pyelonephritis in humans (75). 
Since frequent phase variation or antigenic variation occurs for adhesins of 
some bacteria, an adhesin vaccine may not be protective in such circumstances. 
This limitation led to development of synthetic vaccines which consist of synthetic 
peptides corresponding to conserved regions of an adhesin (124). This approach 
was successful with the P fimbriae of E. coli, but failed with the fimbriae of 
gonococci (124). The M protein of streptococci is highly variable at the N-terminal, 
18 
while the surface exposed C-terminal is conserved. Synthetic peptides 
corresponding to residues within the C-terminal were linked to the mucosal 
adjuvant cholera toxin B subunit (14). This conjugate vaccine significantly reduced 
the colonization of streptococci in pharyngeal mucus of mice. 
Mice immunized intraperitoneally or intramuscularly with purified FHA of B. 
pertussis had significantly reduced bacterial colonization in the lungs (73). This 
protection was mediated primarily by serum antibodies to FHA, which transudate to 
respiratory secretions, because intravenous inoculation of anti-FHA antibodies 
alone produced a similar protection. The protective efficiency of FHA vaccines was 
further confirmed by mucosal immunization, in which mice immunized intranasally 
or intraduodenally with FHA prior to B. pertussis aerosol challenge resulted in a 2 
to 3 log reduction in the number of bacteria recovered from the lungs and the 
tracheas (127). This result indicated that gut mucosal immunization with a major 
adhesin of a respiratory pathogen generated a protective immune response in the 
respiratory tract. 
There are a few examples showing that receptor analogues have the 
potential to block in vivo adherence and infection. In a mouse infection model, 
mannosides reduced the colonization of E. coli'm the urinary tract (5, 157). 
Globotetraose, a receptor analogue for P fimbriae of E. coli, also decreased 
bacterial persistence in the same model (136). Lactoseries oligosaccharides in 
human milk were shown to inhibit adherence of pneumococci, such as H. 
influenzae and S. pneumoniae, to respiratory tract epithelial cells (137). In vivo 
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studies demonstrated tiiat babies receiving milk with high activity of the receptor 
analogue had reduced nasopharyngeal colonization and frequency of otitis 
compared to children receiving milk with low inhibitory activity (137). Unlike 
vaccination, the application of receptor analogues in prevention of bacterial 
infection is still in the experimental stage. 
Mycoplasma adherence 
Mycoplasmas are wall-less organisms, and many of them are mucosal 
pathogens. Membrane-membrane interactions with host cells, especially epithelial 
cells, plays an important role in the initial stage of mycoplasmal diseases (110). 
Most of the studies on mycoplasmal adherent mechanisms have been focused on 
the human mycoplasmas, M. pneumoniae and M. genitalium (110, 143). M. 
pneumoniae attaches to host cells through a specialized tip-structure which was 
first described in the early 1970s (20, 21). Treatment of M. pneumoniae with trypsin 
resulted in loss of a 170 kDa protein designated as PI and concomitant loss of 
adherence of the mycoplasma to eucaryotic cells, while regeneration of PI 
restored adherence of the mycoplasma, indicating that PI is associated with 
adherence (44, 53). Further studies demonstrated that PI is localized at the tip-
structure of /W. pneumoniae (55, 36, 11); monoclonal antibodies against PI 
inhibited adherence of the mycoplasma (55, 36); soiubilized P1 was able to bind to 
host cells (78): and M. pneumoniae organisms that lack PI or were unable to 
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cluster it at the tip organelle failed to attach to respiratory epithelium (79,11). These 
findings strongly indicate that P1 is a major adhesin of M. pneumoniae. 
The gene encoding PI adhesin was identified and characterized. Cloning 
and sequencing of the P1 gene (135, 58) indicated that PI has 20 UGA codons for 
tryptophan, which hampers the production of PI proteins by recombinant 
technology because UGA is recognized as a stop codon in E. coli. PI gene also 
has an unusually long signal sequence consisting of 59 amino acids for 
translocation, no cysteine, and a high content of proline, particularly at the C-
terminus region. About two thirds of the structural gene for PI was found in multiple 
copies in the genome of M. pneumoniae, suggesting that genetic rearrangement 
mechanisms may function for inducing variation in adhesins (135, 132). However, 
the cell-binding domain of P1 is a single-copy region containing 13 amino acids 
(24). These findings imply that the cell-binding domain is conserved, while the 
multiple-copy regions display considerable sequence divergence. Examination of 
PI genes from different isolates of M. pneumoniae revealed significant differences 
in the nucleotide sequences (133, 134). 
The PI gene is part of a three-gene operon, PI operon, which has three 
open-reading frames, ORF-4, PI, and ORF-6 (57, 58). ORF-4 encodes for a 28 kDa 
protein, PI for a 170 kDa protein and ORF-6 for a 130 kDa protein. The function of 
the 28 kDa protein is unknown at present. The 130 kDa protein is cleaved into two 
proteins during maturation, 90 kDa and 40 kDa (129). Both of the proteins are 
absent in the nonadherent avirulent M. pneumoniae strain (B176), indicating the 
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product of ORF-6 is also involved in adherence of M. pneumoniae. A recent study 
has shown that the 90 kDa and 40 kDa proteins are surface exposed and are 
localized at the terminal tip organelle, further confirming their role in adherence 
(37). Coordinated expression of these genes in the operon may be required for 
successful adherence. 
Analysis of adherent and nonadherent mutants of M. pneumoniae 
suggested that multiple proteins might be involved in adherence, although P1 was 
the major adhesin (10, 77). In addition to P1, a 30 kDa protein (P30) has also been 
identified as an adhesin of the mycoplasma, because 1) P30 is clustered at the tip-
structure of M. pneumoniae (10); 2) antibodies to P30 inhibited adherence of the 
mycoplasma to erythrocytes (10); 3) a class of nonadherent mutants lack P30, 
while it is present in wild-type M. pneumoniae (110); and 4) P30 shares 
considerable DNA and protein sequence homology with P1 (23). Besides P1 and 
P30, other membrane proteins are also required for M. pneumoniae adherence. 
Proteins designated HMW1, HMW2, HMW3, HMW4, and HMWS (with molecular 
weights ranging from 140 to 340 kDa) and proteins A, B, C (72, 85, and 37 kDa, 
respectively) were missing in nonadherent mutants, while re-acquisition of these 
proteins lead to reversion of the adherence-positive phenotype (80, 130). The 
functions of these proteins are not defined. The HMW proteins appear to be part of 
the cytoskeieton-like Triton shell of M. pneumoniae and are localized mainly in the 
filamentous extensions of the mycoplasmal cells, in proximity to the tip organelle 
(130). It has been proposed that the HMW and A, B, and C proteins are not real 
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adhesins but are accessory proteins whicli play a role in the lateral movement and 
concentration of the adhesin molecules at the tip-structure, and consequently are 
required for the proper functioning of adhesins (110). 
M. genitalium has a major adhesin similar to PI of M. pneumoniae (54). This 
adhesin, designated as MgPa and with a molecular weight of 140 kDa, is localized 
at the tip structure of M. genitalium. MgPa cross-reacts with PI immunologically, 
and shares extensive homology with PI at both DNA and protein levels (26, 54, 
90), leading to a speculation that the PI and MgPa were the product of a single 
ancestral gene which was conserved during evolution. Monoclonal antibodies 
against MgPa inhibited adherence of M. pneumoniae (54). The MgPa gene is also 
a part of a three-gene operon consisting of three open reading frames (56), 0RF1 
(29 kDa), 0RF2 (160 kDa, MgPa), and ORF3 (114 kDa). Thus, there is a strong 
resemblance to the PI operon of M. pneumoniae. The protein sequences encoded 
by the MgPa operon have considerable homologies with those of the PI operon 
(56). 
M. gaiiisepticum, an avian respiratory pathogen, is another mycoplasma with 
a specialized adherence organelle (89, 141). Antibodies to PI cross-reacted with a 
155 kDa protein of M. gaiiisepticum. However, adherence-inhibiting monoclonal 
antibodies to P1 and MgPa did not react with the 155 kDa protein. Homology 
between P1 gene and the genomic DNA of M gaiiisepticum was demonstrated 
with southern hybridization (25). Polymerase chain reaction, conducted by using 
the oligonucleotide primers derived from the conserved region of P1 and MgPa 
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genes, amplified a 583 base-pair DNA fragment from M. gallisepticum. Subsequent 
cloning and sequencing Indicated that this fragment encoded a 193-amlno acid 
peptide which shares considerable homology to the expected regions of P1 and 
MgPa proteins. This fragment may be a portion of an adhesin gene of M. 
gallisepticum. A common receptor (100 kDa) In human fibroblasts for M. 
gallisepticum, M. pneumoniae, and M. genitalium bound to a 139 kDa protein of M. 
gallisepticum (41). The relationship between the 155 kDa protein and the 139 kDa 
protein and their roles in M. gallisepticum adherence are unknown. Recent studies 
indicated that a 64 kDa protein of M. gallisepticum might be an adhesin of the 
organism since monospecific antiserum Inhibited adherence of the mycoplasma to 
chick tracheal ring organ cultures by as much as 80% (8). The same antiserum also 
caused growth inhibition of M. gallisepticum. Interestingly, the 64 kDA protein cross 
reacted serologically with a 66 KDA protein of M. pulmonis, which Is a putative 
attachment protein of M. pulmonis (86). 
Many other mycoplasmas, such as M. bovis, M. dispar and M. pulmonis, do 
not have specialized adherence structures, although they are able to bind to a wide 
variety of eucaryotic cells (110). Inhibition studies with monoclonal antibodies 
suggested that a 26 kDa surface protein of M. bovis might mediate the adherence 
of the mycoplasma to embryonic bovine lung cells (120). Washburn et al. (150) 
showed that M. arthritidis was able to attach to rat synovial fibroblasts, lung cells, 
and skin cells. A trypsin-sensitlve protein (90 kDa) of M. arthritidis seemed to be 
involved in the adherence because it Is absent In nonadherent mutants and 
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antibodies against it inhibited the adherence (150). 
The chemical nature of host receptors for some mycoplasmas has been 
characterized. Treatment of host cells with neuraminidase indicated that sialic acid-
containing glycoconjugates were receptors for M. pneumoniae, M. genitalium, M. 
gallisepticum, M. synoviae, and M. bovis (120, 109). Further studies with purified 
sialylated glycoproteins or glycolipids confirmed the role of sialic acids in 
adherence of M. pneumoniae (94, 113). More importantly, Loveless and Feizi (96, 
95), utilizing immunofluorescence and immunoelectron microscopy, identified the 
sialo-receptors in human bronchial epithelium, which is a primary site for M. 
pneumoniae infection. They demonstrated that the receptors were polarized at the 
cilia and apical microvillar domains of ciliated cells, whereas the secretory cells 
and mucus lacked the receptors. However, sialylated glycoconjugates are not the 
sole receptors for mycoplasmas. A non-sialylated glycoprotein from human 
fibroblasts was also described as a receptor for M. pneumoniae (40). By utilizing 
thin-layer chromatography overlay assay, Krivan et at. (83) reported that M. 
pneumoniae specifically bound to sulfatide and other sulfated glycolipids including 
seminolipids and lactosylsulfatide. This binding was independent of sialic acid 
moieties and was inhibited by dextran sulfate. A consensus binding sequence in 
the glycolipid receptors was identified as a terminal Gal(3S04)p1 residue. This type 
of receptor was found in human trachea, lung and Widr cells. Sulfated glycolipids 
are common constituents of cell membranes, present in many types of cells (46), 
and play a role in cell adhesion in eucaryotes (35). Mycoplasmas that utilize 
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sulfated glycolipids as receptors include M. pneumoniae, M. hominis, M. 
genitalium, M. salivarium, M. orale, M. hyorhinis, M. arginini, M. pulmonis, and 
Ureaplasma urealytioum (85, 93). 
Because of the importance of adherence in the initiation of mycoplasmal 
diseases, immunization with adhesins should be a plausible approach to 
prevention of mycoplasmal diseases. As an integral and hydrophobic membrane 
protein, the P1 adhesin of M. pneumoniae was very difficult to purify (109). Jacobs 
etai. (64, 63) utilized preparative SDS-PAGE to obtain enough purified PI protein 
to immunize guinea pigs. Guinea pigs immunized intranasally or intraperitoneally 
elicited strong antibody responses to PI; however, these animals were not 
protected from subsequent challenge with virulent M. pneumoniae. In fact, 
immunized guinea pigs had more severe histological lung lesions, manifested by 
infiltration of lymphoid cells, than control animals, indicating that PI induces not 
only a strong humoral response but also an undesired strong cellular response 
which is responsible for development of lung lesions (110). Evaluation of sera from 
patients infected with M pneumoniae revealed that most of the anti-Pi antibodies 
were not against the adherence-mediating epitope but to other sites of PI 
molecules, suggesting the adherence-mediating epitope is not immunogenic (62). 
This finding may provide an explanation for the failure of immunization of guinea 
pigs with P1 adhesins. As Razin and Jacobs proposed (110), the most efficient P1 
vaccine should be one that, on the one hand, induces a strong antibody response 
to the adherence-mediating epitope, and, on the other hand, elicits a low but 
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specific cell-mediated immunity to avoid adverse effects. 
In summary, the adherence of mycoplasmas to host cells is a complex 
process, involving the specific interactions of mycoplasmal adhesins and their 
receptors on eucaryotic cells. Mycoplasmal adhesins are surface proteins, and 
some of them are clustered at a specialized attachment organelle. A mycoplasma 
may have multiple adhesins. Adhesins from different species of mycoplasmas may 
share homology in structure. Two common types of receptors identified for 
mycoplasmas are sialylated glycoconjugates and sulfated glycolipids. Existence of 
multiple adhesins and receptors may provide mycoplasmas with enormous 
flexibility in counteracting the host defense mechanisms. 
Pathogenic mechanisms of M. hyopneumoniae 
M. hyopneumoniae causes mycoplasmal pneumonia of swine (MPS), which 
is one of the most important swine diseases worldwide (116). Even though the 
mortality caused by MPS is low, enormous economic losses may occur due to high 
morbidity, retarded growth and poor feed conversion of infected herds (115). 
Commercial vaccines are now available, but these vaccines do not prevent 
infection, although they significantly reduce development of lung lesions (116). 
Lack of knowledge of the pathogenic mechanisms and virulence factors of the 
mycoplasma has limited the development of more efficient measures for control of 
MPS. 
The incubation period of MPS is about 10 days to 3 weeks (116). Most 
obvious lung lesions are usually observed at 4 to 6 weeks after infection. 
Observations with electron microscopy and immunofluorescence microscopy have 
demonstrated that M. hyopneumoniae colonizes the surfaces of ciliated cells in 
trachea, bronchi, and bronchioles of pigs, whereas few mycoplasmas can be 
observed in alveoli (4, 99,156,15). Invasion of epithelial cells by the mycoplasma 
is not found. In experimental infections, mycoplasmas can be observed on the 
surface of cilia as early as 7 days after inoculation (99). Highest numbers of 
mycoplasmas are obtained at 4 to 6 weeks after infection (4,156). Thereafter, 
mycoplasmas gradually decrease in number and are hardly detectable in the more 
advanced stages of the disease. Attachment of M. hyopneumoniae leads to 
progressive and extensive damage to cilia during in vivo infection (99,156,15, 
140). Under the circumstances without secondary bacterial infection, cilia can be 
regenerated in the late stage of the disease (156,15). M hyopneumoniae tends to 
form microcolonies and accumulates over remaining ciliated cells (99,156, 65). As 
a matter of fact, this mycoplasma only adheres to the cilia of ciliated cells but not to 
other epithelial cells, indicating that adherence to cilia may play an important role 
in colonization and tropism. 
Studies with various in vitro models have generated valuable information on 
the pathogenic mechanisms of M. hyopneumoniae. Adherence and lesions similar 
to in vivo infection were demonstrated in porcine tracheal ring organ cultures 
(65,28). DeBey evaluated ciliostasis and loss of cilia induced by M 
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hyopneumoniae in tracheal organ cultures and found that the damage to cilia 
decreased with in vitro passage of the mycoplasma, which usually reduces the 
pathogenicity of M. hyopneumoniae (28). The damage to cilia was diminished by 
porcine antibodies to M hyopneumoniae, and a 0.1 |j,m membrane that separated 
mycoplasmas from the epithelial cells blocked the cytotoxicity, suggesting that M. 
hyopneumoniae does not secrete toxins and that direct adherence of the 
mycoplasma to ciliated cells is essential for production of ciliary damage. 
Young eta!., who established a hemagglutination assay to characterize the 
adherence mechanisms of M. hyopneumoniae, reported that this organism 
agglutinated turkey red blood cells rather than red blood cells from pigs, guinea 
pigs, sheep, or human beings (154). The hemagglutination was increased by 
treatment of turkey RBC or mycoplasmas with trypsin, suggesting the 
hemagglutinin of the mycoplasma was trypsin-insensitive and the receptor (s) on 
RBC was cryptically presented. Thirteen carbohydrates evaluated in the study did 
not inhibit the hemagglutination. Two monoclonal antibodies to 64 kDa and 41 kDa 
proteins of M hyopneumoniae blocked the hemagglutination, indicating that the 
two proteins might be hemagglutinins. 
M. hyopneumoniae also adhered to cell monolayers including human and 
porcine lung fibroblasts and porcine kidney cells (157). The adherence appeared 
to be mediated by receptor-adhesin interaction because the adherence was 
saturable and inhibited by nonradiolabeled mycoplasmas. Unlike 
hemagglutination, treatment of mycoplasmas with trypsin diminished adherence to 
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cell monolayers, suggesting that the adhesin (s) mediating adherence to cell 
monolayers was different from the hemagglutinins. More recently, Zielinski and 
Ross established a model using single ciliated cells to study adherence of M. 
hyopneumoniae (160). Their results showed that adherence of the mycoplasma 
was polarized at the ciliary tufts of porcine tracheal ciliated cells, and few 
mycoplasmas attached to cell bodies of porcine ciliated cells and to tracheal 
ciliated cells from sheep and rabbit, further confirming the adherence specificity of 
M hyopneumoniae. Treatment of mycoplasmas with trypsin decreased adherence 
in this model, indicating the adhesin (s) wastrypsin-sensitive. However, 
convalescent serum, hyperimmune serum, lung lavage fluid, and many 
carbohydrates did not inhibit the adherence. Tetramethyl urea which disrupts 
hydrophobic interactions and sulfur containing compounds, including dextran 
sulfate, ammonium sulfate, magnesium sulfate, and methionine, inhibited the 
adherence, which led to the conclusion that adherence to porcine ciliated cells was 
mediated by receptor-adhesin interaction as well as hydrophobic interactions. A 
recent study indicated that the cell surfaces of M hyopneumoniae were weakly 
hydrophobic (159). Since the natural target cells (porcine tracheal ciliated cells) for 
M hyopneumoniae were utilized in the single ciliated cell assay, information 
generated from this model should be more meaningful than that from the 
hemagglutination assay and the cell monolayer assay. However, the complicated 
procedures and subjectivity involved in evaluation of results are drawbacks of the 
assay and limit its application in characterization of adherence mechanisms. Thus, 
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improvement of this assay is required for future studies. 
A typical structure of M hyopneumoniae in ultrathin sections consists of 
ribosomes and nuclear materials in cytoplasm, atrilayered cell membrane, and 
undefined layer of materials outside the cell membrane (140,155). No specialized 
organelles, such as the tip structure of M pneumoniae, were observed with M. 
hyopneumoniae. Tajima and Yagihashi compared the ultrastructure of an in vivo-
passaged virulent strain and an in vitro-passaged nonvirulent strain (140). They 
demonstrated that the two strains were very similar in general morphology. 
However, long fibrils and a thicker capsular material were observed outside the 
membrane of the virulent strain. No fibrils and a thinner layer of capsules were 
associated with the nonvirulent strain, which grew poorly in porcine lungs and was 
unable to produce MPS. More importantly, the fibrils and/or the capsular material 
appeared to bridge the interaction of mycoplasmas with cilia during infection (15, 
140). These findings suggested that the fibrils and/or capsule might play a role in 
adherence or virulence of M. hyopneumoniae. The nature of the fibrils and capsule 
remains to be defined. 
Although M hyopneumoniae does not secrete toxins, membrane-associated 
toxins may exist. Geary and Walczak reported that whole cells or purified 
membranes of M hyopneumoniae were cytopathicto porcine lung fibroblasts and 
human lung fibroblasts (42). The cytotoxicity was located in the mycoplasmal 
membranes not in the cytoplasm, and was sensitive to pronase. Further studies 
indicated that the cytopathic factor was a 54 KDa membrane protein with an 
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isoelectric point of 6.2 (39). The effect of the cytopathic factor on porcine ciliated 
cells has not been defined. Minion etal. have recently reported nuclease activities 
associated with M. hyopneumoniae membranes and proposed that, by degrading 
host DNA, the nucleases may play a role in obtaining nucleotide precursors for 
mycoplasmal growth (101). The significance of nucleases in pathogenicity remains 
to be determined. 
Several surface proteins of M. hyopneumoniae, including p70, p65, p50, 
and p44, were identified as lipoproteins (152). The last three lipoproteins were 
shown to be major immunogens of the mycoplasma as detected with convalescent 
swine serum. Recombinant p65 (partial fragments) were expressed in E. coli, and 
mapping with various polyclonal and monoclonal antibodies indicated that the 
immunogenic region of p65 was located in the C-terminal (72). A monoclonal 
antibody to p44 inhibited M. hyopneumoniae growth in vitro (81). The Mab to p70 
recognized a 70 kDa protein in strain J and a 73 kDa protein in strain VPP11, 
indicating that size variation of surface proteins occurs in M. hyopneumoniae (152). 
The biological functions of these lipoproteins are unknown at present. 
Another surface protein with an estimated molecular weight of 74.5 kDa was 
characterized because it was also a major immunogen of M hyopneumoniae 
(142). The genomic DNA for the antigen was cloned in E. coli, and sequence 
analysis indicated that it shares homology with the 70 kDa family of heat shock 
proteins. Thus, the authors proposed that the 74.5 kDa protein was a heat shock 
protein of M hyopneumoniae and designated it as HSP74. Interestingly, a recent 
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study showed that recombinant HSP74 bound to sulfated glycolipids which were 
putative receptors for many mycoplasmas, suggesting that HSP74 may play a role 
in the adherence of M. hyopneumoniae (92). However, solid evidence indicating 
that HSP74 is an adhesin has not been presented. 
The gene encoding a 36 kDa protein of M. hyopneumoniae, which elicits an 
early and strong immunologic response in pigs, was cloned by Strasser etal. and 
the recombinant protein was expressed in E. coli 'm its full length (131). 
Immunocytochemical study showed that the 36 kDa protein was localized in the 
cytoplasm of M hyopneumoniae cells. DNA sequencing indicated that the p36 is a 
lactate dehydrogenase of the mycoplasma (47). Its role in pathogenicity is 
unknown. 
Atypical microscopic lesion of MPS is the peribronchial and perivascular 
infiltration of lymphocytic cells. Since overreaction of immune cells is directly 
responsible for development of inflammation, there is a general notion that the 
infiltrated lymphocytes play a role in causing pneumonia. This hypothesis was 
supported by some evidence derived from in vitro studies in which mitogenic 
activity to porcine lymphocytes was demonstrated with intact M hyopneumoniae 
cells or purified membranes (82,100). The identity and the functions of the 
infiltrated lymphocytic cells are not clear at present. Elucidation of these questions 
may provide valuable information on the pathogenesis of MPS. Other studies 
indicated that M. hyopneumoniae \Nas suppressive to mitogen-induced 
transformation of swine lymphocytes (74). In vivo infection of M. hyopneumoniae 
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did not affect the biastogenic response of porcine peripheral lymphocytes to 
various mitogens, but decreased the humoral response to sheep erythrocytes 
(149). Suppressed functions of alveolar macrophages were found in pigs infected 
with M hyopneumoniae and then with A. pleuropneumoniae (18). 
In summary, multiple virulence factors may be involved in the pathogenesis 
of M /7yopne/7mon/ae infection. One of the most important requirements for 
development of MPS is the adherence of M hyopneumoniae Xo porcine ciliated 
cells. The molecular mechanisms of M. hyopneumoniae adherence to porcine 
ciliated cells have not been defined. The adhesin (s) of the mycoplasma and the 
corresponding receptors on cilia remain to be identified and characterized. More 
efficient measures to control MPS may be developed based on the information 
obtained from adherence studies. 
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MICROTITER PLATE ADHERENCE ASSAY AND RECEPTOR ANALOGS 
FOR MYCOPLASMA HYOPNEUMONIAE 
A paper published in Infection and Innmunity 
Qijing Zhang, Theresa F. Young and Richard F. Ross2 
Abstract 
A microtiter plate adherence assay for Mycoplasma hyopneumoniae was 
established by using purified swine tracheal cilia which contained receptors for the 
mycoplasma. M. hyopneumoniae bound specifically to plates coated with 
solubilized cilia. The binding was dependent on both the concentration of cilia and 
the number of mycoplasmas. Dextran sulfate, heparin, chondroitin sulfate, laminin, 
mucin, and fucoidan significantly inhibited binding of the mycoplasma. The six 
inhibitors also disrupted the adherence of the mycoplasma to intact ciliated cells. 
Preincubation with either mycoplasmas or cilia indicated that heparin, mucin, 
fucoidan and chondroitin sulfate interacted with the adhesive molecules on the 
surface of mycoplasmas, whereas laminin blocked the receptors in cilia. The basis 
for inhibition induced by dextran sulfate was unknown. Treatment of cilia with 
1 Reprinted with permission from Infection and Immunity 1994, 62, 1616-1622. 
Copyright © 1994, American Society for Microbiology. 
2 Corresponding author 
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neuraminidase appeared to promote adiierence of the mycoplasmas, whereas 
treatment of cilia with sodium metaperiodate decreased the binding. These results 
indicate that receptors for M. hyopneumoniae in the ciliated epithelium of the 
respiratory tract of pigs are glycoconjugate in nature. 
Introduction 
Mycoplasma hyopneumoniae is the etiological agent of mycoplasmal 
pneumonia of swine (MPS), an economically important and widely spread swine 
disease (22). This organism is an extracellular pathogen and colonizes the 
respiratory epithelium of pigs. Immunofluorescence tests (1) revealed that large 
numbers of mycoplasmas are primarily located on the luminal surface of trachea, 
bronchi, and bronchioles. Few of them can be found in alveoli. Electron microscopy 
(3,17, 30) demonstrated that M. hyopneumoniae attaches only to ciliated cells, not 
to other types of epithelial cells, and that the organism causes progressive damage 
to cilia during infection. These data strongly indicate that cilia have specific 
receptors for mycoplasmal adherence. Damage to the muco-ciliary system results 
in inflammation and compromises the defense mechanisms of the porcine 
respiratory tract, predisposing to infections by other bacteria and viruses (22). 
Virulence factors of M. hyopneumoniae have not been characterized. However, 
adherence to ciliated cells is considered an important event in determining tropism 
and colonization. 
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M. hyopneumoniae adheres only to ciliated cells in vivo, but it can attach to 
different types of cells in vitro, including turkey red blood cells (29), cell monolayers 
(33), and single ciliated cells of the swine respiratory tract (31). Several adherence 
models have been established based on these findings. However, turkey red blood 
cells and cell monolayers may not represent the natural target cells to which M. 
hyopneumoniae adheres. The single ciliated cell adherence assay (SCCAA), 
utilizing the natural target cells and mimicking the in vivo adherence of M. 
hyopneumoniae, provides a very useful model for characterization of adherence 
mechanisms of M. hyopneumoniae (31). However, the complexity in the procedure 
and the relatively subjective evaluation of results limit its routine use in the 
laboratory. Due to lack of a reliable adherence model, receptors and adhesins 
involved in adherence of M. hyopneumoniae have not been characterized. In this 
study, a microliter plate adherence assay (MPAA) was established by utilizing 
purified cilia which contain receptors for M hyopneumoniae. Receptor analogues 
that block adherence were identified with the MPAA. By defining the nature of 
molecules involved in adherence, we expect to provide more information on the 
pathogenesis and further insight into the development of control measures for 
MPS. 
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Materials and methods 
Chemicals and reagents. Antibodies to M. hyopneumoniae were 
produced by immunizing rabbits witli immunogens prepared in rabbit muscle 
infusion medium supplemented with 20% rabbit serum (19). Peroxidase-
conjugated goat anti-rabbit IgG was purchased from Cappel (Durham, NC). 
Peroxidase substrate (ABTS) was from Kirkegaard & Perry Laboratories, Inc. 
(Gaithersburg, MD). Fluorescein isothiocyanate (FITC)-conjugated antibodies 
against M. hyopneumoniae were supplied by B. Erickson, Iowa State University, 
Ames, Iowa. Various sugars and glycoconjugates were obtained from Sigma 
Chemical Co. (St. Louis, MO) unless otherwise indicated. 
Mycoplasma. M. hyopneumoniae strain 232 LI27 was originally derived 
from strain 11. Passages 1 to 5 were cultured in Friis mycoplasmal medium (9) for 
24 h at 37°C. Mycoplasmas were harvested by centrifugation at 25,000 x gfor 15 
min. Color changing units (CCD) representing the number of mycoplasmas were 
determined by serial dilution in tubes containing Friis medium. The pellet of 
mycoplasmas was resuspended to 1/10 of the original volume in RPMI 1640 
medium containing 1% gelatin (adherence buffer, AB). This preparation was further 
diluted in AB before addition to microtiter plates. For investigation of the effect of in 
vitro passage on adherence, the infected lung homogenate (LI27) was passaged in 
Friis medium. Cultures at passages 3, 10, 20, 30, 40, 50, 60, and 70 were collected, 
washed, and adjusted to contain 12.5 and 25 |ig/ml protein. 
Preparation of cilia. Specific-Pathogen-Free (SPF) pigs free of M. 
hyopneumoniae, 7 to 12 weeks old, were obtained from a herd maintained at the 
Iowa State University Animal Resources Station. The herd was originally 
established from cesarean-born, isolation-reared swine and was a mixture of 
Yorkshire and Hampshire bloodlines. Swine tracheas were collected as described 
(31). Briefly, the pigs were euthanatized, and the tracheas and lungs were 
exposed. The tracheas were clamped at the larynx and separated from the lungs 
by cutting at the bifurcation. Other connective tissues were trimmed from the outer 
surface of tracheas, and then the tracheas were washed three times by immersing 
in RPMI 1640 medium before they were cut into small fragments. Ciliated cells 
were collected by scraping the inner surface of tracheas with a sterilized stainless 
steel laboratory spoon. Cilia were extracted from ciliated cells according to 
methods by Tuomanen et al. (28). Briefly, ciliated cells were suspended in 40 ml 
buffer containing 20 mM Tris, 10 mM EDTA, and 125 mM sucrose (TES, pH 7.2). 
Two washings with the TES buffer were conducted by centrifugation at 300 x g for 5 
min. The cell pellet was resuspended in 6 ml AES (80 mM acetate, 10 mM EDTA, 
125 mM sucrose, pH 6.8) buffer and incubated for 5 min at 25°C. Then, 0.2 M 
CaCl2 was added to a final concentration of 10 mM. The mixture was vortexed for 
10 min, diluted with 20 ml TES buffer, and then centrifuged at 500 x gfor 10 min. 
The sediment which contained mainly cell bodies was saved, and the supernate 
containing cilia was harvested by centrifugation at 18,000 x gfor 15 min at 4°C. The 
ciliary pellet was washed twice with phosphate-buffered saline (PBS) and stored at 
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-70°C until use. Purity of cilia was ascertained by light microscopy. Protein 
concentration was determined using the BCA* protein assay reagent (Pierce, 
Rockford, IL.) according to the instructions provided with the product. Usually, 6 to 8 
mg of ciliary proteins were obtained from a trachea collected from a pig weighing 
100 to 150 pounds. 
Coating plates. Purified cilia (2 mg/ml in PBS) were solubilized with 
sodium dodecyl sulfate (SDS, 1 mg/mg protein) at 37°C for 45 min. This 
preparation was further diluted with sodium carbonate buffer (0.1 M, pH 9.5) to a 
final concentration of 10 |ig/ml protein. To each well of a flat bottom microtiter plate 
(lmmulon®2, Dynatech Laboratories, Inc., Chantilly, VA) was added 100 |xl of the 
solution. The plates were incubated overnight at room temperature and stored at -
70°C without removal of the coating solution. Coated plates were stored at -70°C for 
at least one year without loss of adherence ability. Porcine albumin (fatty acid free, 
10 |j.g/ml) and gelatin (10 ixg/ml) were coated onto plates under conditions used for 
cilia as negative controls. After deciliation, cell bodies of ciliated cells were also 
solubilized and immobilized onto microtiter plates (10 |ig/ml protein). 
Microtiter plate adherence assay. After 4 washings with PBS ( pH 7.4), 
the cilia-coated plates were blocked with 200 lal/well of AB for 2 h at 37°C. Then, 
100 |j,l of M. hyopneumoniae cells resuspended in AB were added to each well, 
and the plates were incubated at 37°C for 90 min. Non-adherent mycoplasmas 
were removed by four washings with PBS. Subsequently, 100 |il of rabbit 
antibodies to M. hyopneumoniae was added and incubated at 37 °C for 60 min. 
The wells were washed 4 time with PBS and then incubated with 100 |liI of goat 
anti-rabbit peroxidase conjugate for 60 min at 37°C. After 4 washings with PBS, 
100 |Lil ABTS was added to each well and incubated at 25 °C for 10 min. Optical 
density (OD) values at 405 nm were measured with an automated micropiate 
reader (Model EL310, Bio-Tek Instruments, Inc., Winooski, VT). Binding of 
mycoplasmas to cell body-coated plates was detected as described above. 
Adherence inhibition. For inhibition assays, various carbohydrates and 
glycoconjugates (Table 1) diluted to appropriate concentrations in AB were mixed 
with mycoplasmas and added to cilia-coated plates. After incubation and washings, 
binding of mycoplasmas to the plates was detected with rabbit anW-M. 
hyopneumoniae antibodies, and goat anti-rabbit conjugates as described 
previously. In order to optimize the sensitivity to interference, 2.5 x lO^ CCU of 
mycoplasmas were utilized in each well so that the OD values from the non-
inhibitory controls were about 0.5, which was in the linear range of the adherence 
curve (Fig. 1). Two approaches were utilized to study competitive inhibition: 1) 
competitors were preincubated with mycoplasmas at 37°C for 1 h, unbound 
competitors were removed by differential centrifugation (25,000 x gfor 15 min), and 
incubated mycoplasmas were applied to cilia-coated plates; 2) cilia-coated plates 
were preincubated with competitors at 37°C for 1 h, unbound competitors were 
removed by four washings, then mycoplasmas were added to the plates. 
Thereafter, procedures for both approaches were identical, including sequential 
addition of antibodies to mycoplasmas, secondary antibody conjugates, and 
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peroxidase substrates. Percentage of inhibition was calculated as follows: % 
inhibition = (OD value from AB - OD value from an inhibitor)/OD value from AB. I^o 
representing the concentration of a competitor that resulted in 50% inhibition was 
determined from the inhibition kinetics obtained with multiple concentrations of a 
competitor. 
Single ciliated cell adherence assay. Substances determined to have 
inhibitory activity with the MPAA were further evaluated using the SCCAA (31). 
Briefly, single ciliated ceils were brushed off the epithelial surface of a trachea from 
a SPF pig and resuspended in RPMI 1640 medium. Cells were washed, counted, 
and resuspended in the medium to 10^ cells/ml. One ml of ciliated cells was mixed 
with 25 |il of mycoplasmas (lO""® CCU/ml) and 25 |i.l of inhibitor diluted to the 
appropriate concentration (Table 4). After incubation in a water bath for 90 min, free 
mycoplasmas were removed by centrifugation (500 x gfor 10 min). Cell pellets with 
associated mycoplasmas were washed twice with PBS and pipetted to glass 
slides. Air-dried, methanol-fixed slides were stained with FITC-conjugated 
antibodies to M. hyopneumoniae and observed under UV light with a Nikon 
epifluorescence microscope. The fluorescent score (an estimation of the number of 
mycoplasmas bound to a ciliated cell) for each sample was calculated as reported 
previously (31). 
Treatment of cilia with neuraminidase and sodium 
metaperiodate. Purified cilia were incubated with 10 mM or 100 mM sodium 
metaperiodate in 10 mM sodium acetate (pH 5.0) at 37°C for 30 min, then washed 
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three times with PBS, soiubilized with SDS, and coated onto microtiter plates 
according to methods described previously. Cilia treated with 10 mM sodium 
acetate only were utilized as the controls. Adherence of M. hyopneumoniae \o 
treated cilia was evaluated by the standard procedures. For treatment with 
neuraminidase, purified cilia were incubated with neuraminidase (1 unit/ml in 10 
mM sodium acetate, pH 5.0) at 37°C for 30 min. After three washings with PBS, the 
treated cilia were soiubilized with SDS and coated onto microtiter plates. 
Adherence was evaluated according to the standard procedures. 
Statistics. Analysis of variance with the Tukey contrast at a significance 
level of 0.05 was utilized for comparison among multiple treatments in an assay. 
The Student t test was used if only two treatments were evaluated. 
Results 
Development of MPAA. M. hyopneumoniae bound specifically to cilia-
coated wells but not to control wells coated with gelatin or porcine albumin (Fig. 1). 
OD values obtained with the control wells were always less than 0.08. The degree 
of binding was influenced by both the number of mycoplasmas and the 
concentration of cilia utilized for coating plates. The optimum concentration of cilia 
for coating plates was 1 iig protein per well. About 2 x 10^ mycoplasmas were 
required for half-maximal binding at 37°C. Saturated binding was observed with 
more than 1 x 10^ CCD mycoplasmas per well. Compared to 37°C, the binding 
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activity of M. hyopneumoniae was about 3 times lower at 25°C and minimal at 4°C. 
Similar adherence patterns were observed with solubiiized mycoplasmas at 
different temperatures (37 °C, 25 °C and 4 °C). The adherence was also time-
dependent, with an optimum incubation time of 90 min (data not shown). Prolonged 
incubation resulted in increased background values. Well-to-well or plate-to-plate 
difference was negligible (<5%). Mycoplasmas resuspended in PBS or RPMI 1640 
medium adhered equally well to cilia-coated plates (data not shown), although the 
latter was utilized throughout this study. Mycoplasmas solubiiized by SDS or 
sonication also had the ability to adhere. In fact, solubiiized mycoplasmas had 
higher adherence activity than intact mycoplasmas (data not shown). Heating of 
mycoplasmas (both intact cells and solubiiized mycoplasmal proteins) at 56°C for 
30 min resulted in an 80% reduction in adherence. With increased passage level, 
M. hyopneumoniae gradually decreased in adherence activity (Fig. 2), with a 
significant decrease starting at passage 50 (P<0.01). Solubiiized mycoplasmas 
displayed a similar trend of decreased adherence with increase in passage level 
(data not shown). Mycoplasmas bound equally well to cell body-coated wells and 
to cilia-coated wells (data not shown). 
Adherence inhibitors. Since host cell surface receptors for mucosal 
pathogens are usually carbohydrate in nature, we evaluated the binding of the 
mycoplasma in the presence of various sugars and glycoproteins. In order to 
facilitate screening, competitors and mycoplasmas were added at the same time to 
cilia-coated plates. Among the carbohydrates and glycoconjugates evaluated in 
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this experiment, dextran sulfate, heparin, fucoidin, chondroitin sulfate, mucin and 
laminin inhibited adherence of M. hyopneumoniae (Table 1). Three different 
molecular weights of dextran sulfate produced similar inhibition kinetics and 
inhibited adherence as much as 90%, but dextran was not an efficient competitor. 
Other sulfated compounds including D-galactose-6-sulfate, D-glucose-6-sulfate, N-
acetyl-glucosamine-3-sulfate and N-acetyl-glucosamine-6-sulfate had no effect on 
binding of M. hyopneumoniae. Tetramethyl urea, which disrupts hydrophobic 
interactions, magnesium sulfate and methionine did not inhibit adherence. Mucin 
from porcine intestine produced 75% inhibition. When compared at concentrations 
of 20, 200, and 1,000 |ig/ml, mucin from bovine submaxillary glands produced 
substantially lower inhibition than mucin from porcine intestine (data not shown). 
Actually, inhibition by bovine mucin never exceeded 30% at concentrations of up to 
2 mg/ml. Remarkable differences in inhibition were obtained among chondroitin 
sulfate A, B, or C. Chondroitin sulfate B and chondroitin sulfate A had an l^o of 20 
iag/ml and 80 |ig/ml, respectively, while no inhibition occurred with chondroitin 
sulfate C at concentrations of up to 2 mg/ml. Sialic acid had no effect on 
adherence. Partial inhibition (<50%) was obtained with fetuin, a glycoprotein rich in 
sialic acids. Asialofetuin and asialomucin, which were derived from fetuin and 
mucin (bovine submaxillary glands), respectively, and chemically modified to 
remove surface sialic acids, had significantly higher inhibition activity than fetuin 
and mucin (Table 2). 
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Table 1. Glycoconjugates evaluated for inhibition of adiierence 
Chondroitin sulfate C 
D-fucose 
D-galactose 
D-galactose-6-sulfate 
D-glucose 
D-glucose-6-sulfate 
D-mannose 
Dextran 
DEAE dextran 
Dextran sulfate MW 5,000 <1 
Dextran sulfate MW 8,000 5 
Dextran sulfate MW 500,000 <1 
Diacetylchltobiose 
Fetuln * 
Fucoidan <1 
Galactopyranosyl-galacto-pyranose 
Heparin <1 unit/ml 
Hyaluronic acid 
L-fucose 
Lactose 
Laminin 50 
Lactoferrin 
Melibiose 
Mucin {bovine submaxillary glands) * 
Mucin (porcine intestine) 40 
N-acetyl-galactosamine 
N-acetyl-glucosamine 
N-acetyl-neuramin-lactose 
N-acetyl-mannosamine 
N-acetyl-lactosamine 
N-acetyl-glucosamine-3-sulfate 
N-acetyl-glucosamine-6-sulfate 
Sialic acid 
MgS04 
Methionine 
Tetramethyl urea 
Name 
Asialofetuin 
Asialomucin (bovine submaxillary glands) 
Chondroitin sulfate A 
Chondroitin sulfate B 
*b 
80 
20 
® Concentration (|xg/ml, unless indicated) that resulted in 50% inhibition. 
Partial inhibition was observed, but not more than 50% at the maximum concentration (2 mg/ml) tested. 
No inhibition was detected at concentrations of up to 2 mg/ml. 
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Table 2. Effect of sialylation on adherence 
Concentration % inhibition® by: 
(lig/mi) 
Mucin Asialomucin Fetuin Asialofetuin 
10 2.9 + 2.9 6.6 ±4.8 ND ND 
50 ND ND 3.9 ±7.1 19.3 ± 4.6b 
100 25.9 ±3.3 30.9±1.6c ND ND 
500 ND ND 27.2 ± 4.3 48.9 ± 3.4b 
3 Mean % inhibition ± SD in three experiments. 
^ P< 0.01 versus fetuin as determined by student t test, 
c P< 0.05 versus mucin as determined by student t test. 
ND: not determined. 
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Inhibitory mechanisms. It was speculated that positive results obtained in 
the adherence assay with various carbohydrates and glycoconjugates could have 
resulted either by interference with adhesins of mycoplasmas or by interference 
with receptors on cilia. The effects of the six competitors were further evaluated by 
preincubating them with mycoplasmas or with cilia. When preincubated with 
mycoplasmas, fucoidin, heparin, chondroitin sulfate B and mucin significantly 
blocked binding of the mycoplasma; laminin (6%) and dextran sulfate (16%) 
resulted in limited inhibition (Table 3). When the six competitors were pre­
incubated with cilia, laminin produced 75% inhibition, whereas fucoidan produced 
27% which was much less than that from preincubation with mycoplasmas; the 
other 4 competitors had no inhibitory effect. The six competitors also significantly 
reduced attachment of M. hyopneumoniae to intact ciliated cells in the SCCAA 
(Table 4). The effect of the six competitors on the detection of M. hyopneumoniae 
with antibodies was evaluated by ELISA. Microtiter plates coated with M. 
hyopneumoniae were incubated with the detecting antibodies in the presence of 
heparin, mucin, dextran sulfate, fucoidan, chondroitin sulfate, and laminin. There 
was no significant difference in OD values between the wells with the competitors 
and the control wells without the competitors, indicating that these substances 
impacted the mycoplasma-cilia interaction rather than the detection process. 
Effect of neuraminidase and sodium metaperlodate on 
adherence. Pretreatment of cilia with neuraminidase resulted in a trend toward 
increased binding of M. hyopneumoniae (Fig. 3), although the increase was not 
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Table 3. Inhibitory mechanisms of different competitors 
Treatment % inhibition^ produced by preincubation with 
(ng/mO 
cilia mycoplasmas 
Laminin (200) 74.8 + 0.6b 6.2 + 5.8 
Mucin (200) -6.6 + 6.6 78.3 ± 3.1 
Dextran sulfate MW 500,000 (100) 0.5 + 6.7 16.4 + 20.2 
Chondroitin sulfate B(200) -1.3 + 0.4 45.6 ± 15.5 
Fucoidan (100) 27.0 + 3.5 77.6 + 6.8 
Heparin (10 units/ml) -2.2 + 6.2 93.4 + 11.5 
® % inhibition was calculated versus adherence buffer. 
^ Mean % inhibition ± SD in triplicated assays. 
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Table 4. Inhibition of mycoplasmal adherence to intact ciliated cells^ 
Inhibitor (jig/ml) Adherence (fluorescence score)^ 
RPMl 1640 21.6 ± 6.0 
Dextran sulfate MW 500,000(10) 1.8 ± 1.4c 
Heparin (10 units/ml) 8.2 ± 4.7c 
Laminin (200) 12.3 ± 5.3° 
Fucoidan (100) 1.1 ± 0.8C 
Mucin (200) 2.1 ± 1.7c 
Chondroitin sulfate B (100) 9.4 + 4.9c 
3 Adherence was conducted with the SCCAA model in the presence of the 
inhibitors. 
^ Means ± SD in duplicate experiments. 
^ Significantly different from RPMl 1640 as determined by analysis of variance with 
the Tukey contrast (P<0.05). 
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significant. In contrast to neuraminidase, pretreatment of cilia with sodium 
metaperiodate, which perturbs carbohydrate structure, significantly reduced 
attachment (Fig. 3). 
Discussion 
Results from this study indicated that the MPAA is specific and reproducible. 
Compared with other assays, this model is more objective and sensitive. MPAA 
provides a convenient method for evaluation of adherence mechanisms of M. 
hyopneumoniae. It is not feasible to screen large numbers of adherence 
competitors by the SCCAA because of its limitations. However, many samples can 
be easily analyzed using the MPAA, resulting in identification of receptor 
analogues. Furthermore, the nature of receptors may also be determined using this 
model. 
Data from the study demonstrated that adherence of M. hyopneumoniae is 
temperature and dose dependent. Lysed mycoplasmas had higher adherence 
activity than intact mycoplasmas, indicating that viability of M. hyopneumoniae is 
not required for successful binding and that solubilization of mycoplasmal 
membranes may expose more binding sites. Similar findings were reported with 
Mycoplasma galliseptioum (12). Unlike M. pneumoniae, which did not adhere well 
in nutrient-deficient medium (14), M. hyopneumoniae did not require glucose for 
binding because mycoplasmas resuspended in RPMI and PBS bound equally well. 
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This observation was consistent with a previous finding in which metabolically 
active M. hyopneumoniae were not required for binding in the SCCAA (31). 
Heating (56°C for 30 min) mycoplasmas before adherence remarkably decreased 
binding, indicating that adhesin (s) of M. hyopneumoniae is sensitive to heat. This 
sensitivity to heat could have resulted from conformational changes in binding sites 
of mycoplasmal adhesins rather than an impact on metabolic activity because M. 
hyopneumoniae need not be metabolically active for successful binding. Reduced 
adherence at low temperatures (4 °C and 25 °C) could be caused by decreased 
thermal motion of particles or molecules, the number of molecular collisions, and 
consequently, the speed of specific ligand-receptor interactions. A high passage 
culture of M. hyopneumoniae was reported to be unable to cause pneumonia in 
pigs (32). Attenuation of virulence through successive in vitro passages was also 
obtained with other mycoplasmas (4, 27). In this study, the adherence capability of 
M. hyopneumoniae to SDS-solubilized cilia was gradually decreased by passage 
in Friis medium (Fig. 2). This change in adherence appears to parallel the 
decrease in pathogenicity of the mycoplasma (32). We speculated that a selective 
variation of mycoplasmal adhesins might occur with the increase in passage level, 
therefore leading to reduced capability of attachment. 
Six adherence inhibitors were identified in this study (Table 1). Four of them, 
fucoidan, heparin, chondroitin sulfate and mucin, bound to the ligands on the 
surface of mycoplasmas and therefore were receptor analogues. They are all 
sulfated glycoconjugates, which indicates that sulfonation of carbohydrate chains is 
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important for receptor activity. However, sulfate alone was not sufficient for 
mycoplasmal binding since other sulfated carbohydrates including D-glucose-6-
sulfate, D-galactose-6-sulfate, N-acetyl-glucosamine-3-sulfate, N-acetyl-
glucosamine-6-sulfate and SO4-2 had no effect on attachment. The inhibitors are all 
polyanionic molecules. The only structural difference between chondroitin sulfate A 
and C is the position of sulfate (24). Chondroitin sulfate A inhibited adherence of 
the mycoplasma, whereas chondroitin sulfate C did not. This finding indicates that 
the inhibition is probably not due to ionic interaction since chondroitin sulfate A and 
chondroitin sulfate C have similar charge properties. Chondroitin sulfate B, which 
contains iduronic acid instead of glucuronic acid found in chondroitin sulfate A 
(24), caused significantly higher inhibition than chondroitin sulfate A. These results 
suggest that the binding affinity of M. hyopneumoniae to cilia is greatly affected by 
the nature of carbohydrates and positions of sulfate on carbohydrate chains. 
The animal cell surface is covered by various forms of carbohydrates (13). 
Many viruses (7), bacteria (23), and bacterial toxins (8) utilize eucaryotic cell 
surface carbohydrates as attachment sites, which is an essential process for 
establishment of colonization and production of toxic effects. In this study, the 
inhibition of adherence by several carbohydrates and the decreased binding 
caused by treatment of cilia with sodium metaperiodate strongly suggest that the 
receptors for M. hyopneumoniae are sulfated glycoconjugates. Both sulfated 
complex carbohydrates and sialylated glycoconjugates were demonstrated in rat 
(26), dog and human (25) respiratory epithelium and in bronchial goblet cells of 
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pigs (6). Tliese data indicate that sulfated carbohydrates are available in vivo for 
attachment of pathogens that colonize respiratory epithelium. 
Many types of eucaryotic cells have membrane-associated heparin or 
heparin-like polysaccharides, which facilitate cell-cell interactions and cell-
extracellular matrix interactions (5, 21). It is not known if ciliated cells have surface 
exposed heparin or heparin-like polysaccharides. M. hyopneumoniae may utilize 
this natural substratum for attachment. However, further experiments are required 
to verify this hypothesis. Dextran sulfate produced more than 90% inhibition when 
mixed together with mycoplasmas and cilia, but it caused limited inhibition (16%, 
Table 3) when preincubated with mycoplasmas. We speculated that this 
discrepancy might be caused by the low affinity of dextran sulfate for mycoplasmas. 
After preincubation, dextran sulfate could be removed from mycoplasmas by the 
washing step in the adherence assay. Laminin, a glycoprotein with a large 
molecular weight, did not interact with molecules on mycoplasmas. It was reported 
that laminin binds specifically to sulfated glycolipids (20). Also, sulfated glycolipids 
are receptors for several species of mycoplasmas (14,15). Perhaps, laminin binds 
to glycolipid receptors in swine cilia and therefore inhibits adherence of M. 
hyopneumoniae. Sialic acid has been reported to be a receptor site for bacteria 
(11), viruses (16) and mycoplasmas (10,18). Results of this study demonstrated 
that sialic acid is not involved in adherence of M. hyopneumoniae. In fact, removal 
of sialic acids from cilia appeared to promote adherence of M. hyopneumoniae 
(Fig. 3). This trend is correlated with increased inhibition from asialomucin and 
57 
asialofetuin (Table 2). Sialic acid is usually on the terminal position in 
oligosaccharide chains. Removal of it may either change the charge properties on 
cilia or uncover more receptor epitopes for the mycoplasma. It is not known 
whether M. hyopneumoniae produces neuraminidase during infection. 
Secretion of large amounts of mucus during MPS seems to be a host 
defense mechanism to trap microbes such as M. hyopneumoniae. However, this 
mycoplasma causes extensive damage to cilia (3, 17, 30) by unknown means, 
which compromises the major clearance system in the swine respiratory tract. 
Thus, adherence to mucin may promote the infection of M. hyopneumoniae since 
secretions can not be efficiently excluded from the respiratory tract due to 
malfunction of the muco-transportation system. DeBey et al. (6) quantitated 
bronchial goblet cell secretions of pigs by image analysis of sections stained with 
high iron diamine/Alcian blue. The results revealed that bronchial goblet cells of 
pigs infected with M. hyopneumoniae contained significantly less sialomucin and 
more sulfomucosubstances than goblet cells of control pigs. This finding suggests 
that goblet cells of pigs altered production of type of mucosubstances in response 
to infection with the mycoplasma. 
Adherence of M. hyopneumoniae to swine ciliated cells is a complicated 
process. In order to reach ciliated cells, the mycoplasma must overcome the 
sweeping force and penetrate the mucus gel which covers the surface of 
epithelium. Receptor-ligand interactions as well as hydrophobic interactions may 
contribute to this process (31). It was speculated (31) that the hydrophobic 
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interactions initiated the first phase of adherence (nonspecific and low affinity), and 
the adhesin-receptor interaction mediated the second phase (specific and high 
affinity). Tetramethyl urea, which disrupts hydrophobic interactions, partially 
inhibited adherence in the SCCAA model (31), but it did not inhibit adherence in 
the MPAA (Table 1). This discrepancy might suggest that in the MPAA, where the 
ciliary membranes were solubilized and the receptor (s) was directly exposed to 
mycoplasmas, the hydrophobic interactions were no longer necessary for the 
adherence. Under the conditions utilized with the MPAA, adherence is mainly 
adhesin-ligand mediated since 1) M. hyopneumoniae did not bind significantly to 
microtiter plate wells without coated cilia (Fig. 1); 2) receptor analogues inhibited 
the adherence by as much as 90%; and 3) tetramethyl urea did not interfere with 
adherence (Table 1). 
M. hyopneumoniae also attached to the cell body of ciliated ceils in the 
MPAA model, indicating presence of receptors in the plasma membrane of ciliated 
cells. Although the distribution of some membrane surface components may be 
polarized at different locations in the plasma membrane of ciliated cells, it seemed 
that the receptor (s) for M. hyopneumoniae was present in both the ciliary 
membrane and the luminal membrane of ciliated cells. This finding was not 
consistent with results obtained by the SCCAA model in which this mycoplasma 
predominantly bound to the ciliary tuft and only a few to cell bodies (31). This 
contradiction may be explained by varied accessibility of receptors on different 
locations of ciliated cells. These findings suggest that host receptors that interact 
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with adhesins of a pathogen are not the sole factor for tissue tropism. 
The six inhibitors obtained with MPAA also blocked the attachment of M. 
hyopneumoniae to intact ciliated cells (Table 4), indicating adherence mechanisms 
involved in the MPAA were comparable with those operating in the SCCAA. In the 
SCCAA, intact ciliated cells instead of solubilized cilia were utilized to react with 
mycoplasmas. This result confirmed the specificity of the receptor analogues which 
interrupt the intimate associations between molecules on the surfaces of 
mycoplasmas and ciliated cells. No antibodies against M. hyopneumoniae have 
been identified that blocl< the adherence, which makes isolation of adhesins 
difficult. Thus, these receptor analogues provide a valuable alternative approach 
for purification and characterization of mycoplasmal adhesins in the future. In 
addition, novel approaches to the prophylaxis of MPS may be developed by 
utilizing the receptor analogues. It was reported by Aronson et al. (2) that mannose, 
a receptor analogue for type 1 fimbriated E. ooli, successfully decreased episodes 
of cystitis when instilled with the organism into the mouse bladder. 
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HYOPNEUMONIAE TO PORCINE RESPIRATORY CILIATED CELLS 
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Abstract 
Glycolipid receptors for Mycoplasma hyopneumoniae attachment were 
analyzed by using a thin-layer chromatography (TLC) overlay assay. M. 
hyopneumoniae bound specifically to sulfatide, globoside, and 
monosialoganglioside GM3. No binding was detected to sphingomyelin, 
cerebroside, lactosyl ceramide, ceramide trihexoside, monosialogangliosides GM1 
and GM2, disialogangliosides (GD1a, GD1b, and GD3), trisialoganglioside (GT1b), 
cholesterol, cholesterol sulfate, palmitic acid, tripalmitin, or cholesteryl palmitate. 
Total lipids extracted from cilia of the swine respiratory epithelium also were 
separated on TLC plates and overlaid with mycoplasmas. M. hyopneumoniae 
bound specifically to three ciliary glycolipids identified as La, Lb, and Lc. Binding 
to Lc was stronger than to La and Lb. All three lipids were sulfated glycolipids as 
determined by laminin binding. Lc had a mobility similar to that of sulfatide on TLC 
plates, but it was barely detectable when reacted with orcinol ferric chloride 
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reagent. Homogeneous ciliary glycolipid receptors were successfully purified from 
a ciliary lipid mixture and immobilized onto microtiter plates. Sensitive and dose-
dependent binding of M. hyopneumoniaeXo La, Lb, and Lc was detected. Lipid-
extracted cilia had substantially lower adherence activity than did non-extracted 
cilia. These results indicate that the sulfated glycolipids. La, Lb, and Lc, were the 
major native receptors for M. hyopneumoniae attachment in vivo. 
Introduction 
Mycoplasmal pneumonia of swine (MPS), caused by Mycoplasma 
hyopneumoniae, is a worldwide, economically important swine disease (24). Lack 
of knowledge about the pathogenic mechanisms and virulence factors involved in 
M. hyopneumoniae infection is the limiting factor in the development of highly 
effective vaccines for control of MPS. M. hyopneumoniae colonizes the surface of 
ciliated cells in the tracheas, bronchi, and bronchioles of pigs and does not invade 
epithelial cells (1, 24). Intimate attachment of this organism to cilia during infection 
has been well documented (2, 20, 29). This association leads to extensively 
progressive loss of cilia, desquamation of epithelium, and development of 
pneumonia (24). Both in vitro and in vivo studies have shown that M 
hyopneumoniae only adheres to cilia of swine respiratory ciliated cells but not to 
non-ciliated cells of the porcine respiratory tract (2, 20, 29, 30). These data indicate 
that cilia of the porcine respiratory epithelium have receptors for M. 
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hyopneumoniae. 
Mucosal surfaces are the ports of entry and major sites of many infectious 
agents. IVIany pathogens, including viruses (6, 19), bacteria (25), and bacterial 
toxins (8), bind to specific carbohydrate moieties on the mucosal surfaces, enabling 
colonization and infection, and potentially leading to toxic damage to the host cells. 
These carbohydrate moieties may be present in either glycoproteins or glycolipids. 
Although several in vitro adherence models have been established for M. 
hyopneumoniae (27, 28, 30, 31), the adhesin(s) of the mycoplasma and its host 
receptors has not been identified. In a previous study (28), several carbohydrates 
and glycoconjugates including dextran sulfate, heparin, fucoidin, chondroitin 
sulfate, mucin, and laminin inhibited adherence of this mycoplasma to ciliated cells; 
treatment of cilia with sodium metaperiodate before mycoplasmal binding reduced 
the attachment of mycoplasmas. These data strongly indicate that glycoconjugates 
on the surface of the ciliary membrane are involved in the attachment of M. 
hyopneumoniae. In this study, the native glycolipid receptors for M. 
hyopneumoniae were identified by by use of a TLC overlay assay. 
Materials and Methods 
Chemicals and reagents. Neutral glycolipids (cerebroside, sulfatide, 
sphingomyelin, lactosyl ceramide, ceramide trihexoside, and globoside), 
gangliosides (GM1, GM2, GM3, GDI a, GDIb, GD3, GTIb, and asialo-GMI) and 
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non-polar lipids (cholesteryl palmitate, tripalmitin, palmitic acid, cholesterol, and 
cholesterol sulfate) were obtained from Matreya, Inc. (Pleasant Gap, PA). Laminin, 
rabbit anti-laminin antibodies and orcinol ferric chloride spray reagent (Bial's 
reagent) were from Sigma Chemical Company (St. Louis, MO). Polyclonai 
antibodies to M. hyopneumoniae were produced by immunizing rabbits with 
mycoplasmal immunogens prepared in rabbit muscle infusion medium 
supplemented with 20% rabbit serum (21). Peroxidase-conjugated goat anti-rabbit 
IgG was purchased from Cappe! (Durham, NC). Peroxidase substrates, ABTS and 
4-chloro-1-naphthol, were from Kirkegaard & Perry Laboratories, Inc. 
(Gaithersburg, MD). 
Mycoplasma. M. hyopneumoniae strain 232 LI27 was cultured in Friis 
mycoplasmal medium (10) for 24 h at 37°C. Color changing units (CCU), 
representing the number of mycoplasmas in the culture, were determined by serial 
dilution in tubes containing Friis medium. Mycoplasmas were harvested by 
centrifugation at 25,000 x gfor 15 min. The pellet of mycoplasmas was 
resuspended to 1/10 of the original volume in RPMI 1640 medium containing 1% 
gelatin. This preparation was further diluted in the buffer for use in the TLC overlay 
assay and the microtiter plate adherence assay. 
Extraction of total lipids from swine cilia. Ciliated cells were 
harvested from specific-pathogen-free swine trachea as described (30), and the 
cilia were extracted according to the methods of Tuomanen et al. (26). Briefly, 
ciliated cells were harvested from the trachea and suspended in 40 ml TES buffer 
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(20 mM Tris, 10 mM EDTA, and 125 mM sucrose, pH 7.2). The cells were washed 
twice with TES by centrifugation (300 x gr for 5 min). The cell pellet was 
resuspended in 6 ml AES buffer (80 mM acetate, 10 mM EDTA and 125 mM 
sucrose, pH 6.8) and mixed with 6 ml, 20 mM CaCl2. This mixture was vortexed for 
10 min at 25 °C, diluted with TES to 40 ml, and then centrifuged at 500 x gfor 5 
min. The supernate containing extracted cilia was sedimented by centrifugation at 
18,000 x gfor 20 min. Cilia were washed twice with phosphate-buffered saline 
(PBS, pH 7.2) before extraction of lipids. Extraction of total lipids from cilia was 
performed as reported by Magnani et al. (18). Briefly, 0.5 gram wet weight of cilia 
was homogenized in a mixture of 1.5 ml water, 5.4 ml methanol, and 2.7 ml 
chloroform. The homogenate was centrifuged at 5,000 x gior 20 min. The 
supernate was collected, and the pellet was extracted twice more with 0.5 ml water, 
2.7 ml methanol and 1.35 ml chloroform. The supernates from three extractions 
were pooled and evaporated. The residue was dissolved in chloroform-methanol 
(2:1) and extracted 2 or 3 times until nonsoluble substances (proteins) were totally 
removed. The total lipid extract was resuspended in 0.5 ml chloroform-methanol 
and stored at -20°C. The nonsoluble substances in chloroform-methanol (2:1), 
mainly containing ciliary proteins, were dissolved in PBS and stored at -70°C. 
Some of the lipid extract was subjected to Folch partition in six volume chloroform-
methanol (2:1) and one volume water (9). The upper phase was collected, and the 
lower phase was partitioned twice more with six parts chloroform-methanol (2:1) 
and one part water. The upper phases from each partition were pooled. 
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evaporated, dissolved in chloroform-methanol (2:1), and stored at -20°C. 
TLC overlay assay. The TLC overlay assay was performed as described 
(16) with some modifications. Various lipid standards and total lipid extract of cilia 
were applied onto polyester-backed silica gel TLC plates (Sigma Chemical 
Company, St. Louis, MO). The lipids were separated with 
chloroform/methanol/0.25% CaCl2 in water (60:35:8). Two chromatograms were 
developed in parallel on the same plate; one was sprayed with Bial's reagent to 
display any glycolipids, and one used in the overlay assay. After drying, the plates 
for the overlay assay were dipped in 0.5% polyisobutyimethacrylate (Polysciences, 
Inc., Warrington, PA) in hexane for 2 min and air-dried. The coated plates were 
immersed in RPMI 1640 medium containing 1% gelatin at 37°C for 2 h. Then, the 
plates were overlaid with a suspension of M. hyopneumoniae (5x10® CCU/ml) 
and incubated at 37°C for 5 h in a humid atmosphere. Unbound mycoplasmas 
were removed by three washings in PBS, 3 min each time with gentle shaking. 
Rabbit anti-mycoplasma antibodies were added and incubated for 1 h at 37°C. 
After three washings with PBS, the plates were overlaid with goat anti-rabbit IgG 
conjugated with peroxidase at 37°C for 1 h. Binding of mycoplasmas to specific 
lipids was visualized by the addition of 4-chloro-1-naphthol. For identification of 
sulfated glycolipids, plates with separated lipids were overlaid with laminin and 
developed with anti-iaminin antibodies based on the methods described by 
Roberts et al. (23). 
Microtiter plate adherence assay. The microtiter plate adherence 
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assay was performed as previously reported (28). After extraction of cilia with 
chloroform-methanoi, the precipitate (ciliary proteins) was dissolved In PBS, 
solubilized with sodium dodecyl sulfate, and coated onto 96-well microtiter plates 
(10 ng per ml, 100 \i\ per well). Untreated cilia and gelatin were utilized as positive 
and negative controls, respectively. Mycoplasmas, rabbit antibodies to M. 
hyopneumoniae, goat anti-rabbit peroxidase conjugate, and substrate (ABTS) 
were sequentially added to the plates according to standard procedures. Optical 
density (OD) values at 405 nm representing adherence activity were measured 
with a microplate reader (Model EL310, Bio-Tek Instruments, Inc, Winooski, VT). 
Purification of individual glycolipid receptors. Total ciliary lipids 
were separated on a TLC plate. A small portion of the plate was sprayed with Bial's 
reagent to reveal various glycolipid bands. The regions corresponding to the 
individual bands on the remaining plate, which were known to be receptors of M. 
hyopneumoniae, were scraped from the plate and extracted with chloroform-
methanoi (2:1). Solvent was separated from the gel by centrifugation at 23,000 x g 
for 20 min. The extraction was conducted three times, and the solvent was pooled 
and evaporated. The purified receptors were resuspended in chloroform-methanoi 
(2:1). Purity of each preparation was examined by TLC, and the adherence activity 
of each receptor was detected by overlaying with M. hyopneumoniae as described 
in the standard protocol. 
Binding of mycoplasmas to immobilized glycoliplds. This assay was 
performed according to the method reported by Krivan et al. (16) with some 
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modifications. Briefly, sulfatide, glucocerebroside, and purified ciliary glycolipids 
were serially diluted in methanol containing auxiliary lipids (0.1 |Lig/ml cholesterol 
and 0.1 |j.g/ml phosphatidylcholine). Various dilutions of glycolipids were added to 
the wells (100 |il/well) of a 96-well microtiter plate (lmmulon®1) and evaporated. 
Binding of M. hyopneumoniae Xo the immobilized glycolipids was conducted and 
detected with procedures similar to those described for the microtiter plate 
adherence assay. 
Results 
Binding of M. hyopneumoniae to standard glycolipids. Various lipid 
and glycolipid standards were subjected to thin-layer chromatography and tested 
for the ability to bind M. hyopneumoniae (Table 1). M. hyopneumoniae bound to 
sulfatide, GM3, and globoside, but not to GM2, GM1, GD3, GDI a, GDIb, GTIb, 
asialo-GMI, and other neutral, or non-polar lipids which were tested in this 
experiment (Table 1). Binding of M. hyopneumoniae Xo sulfatide and GM3 was 
stronger than to globoside (Fig. 1). Nonspecific binding of antibodies to lipids was 
not detected. Coating of the TLC plates with polyisobutylmethacrylate was 
essential to reduce background binding. Unlike the microtiter plate adherence 
assay in which 90 min of incubation was enough for successful binding of 
mycoplasmas, it was neccessary to increase the incubation time (5 h at 37°C) of 
mycoplasmas for optimal binding in the TLC overlay assay. 
Fig. 1. Binding of M. hyopneumoniae to standard glycolipids on TLC plates. 
Panel A, sprayed with Bial's reagent; panel B, overlaid with M. 
hyopneumoniae. Lane 1, neutral glycosphingolipids: cerebroside (C, 
3 |j.g), lactosylceramide (L, 3 |j.g), ceramidetrihexoside (T, 3 |xg) and 
globoside (G, 3 (xg). Lane 2, sulfatide (2.5 |ig). Lane 3, gangliosides in 
order of their migration (top to bottom); Asialo-GM1 (3 |ig), GM1 (3 |ig), 
GDI a (3 |ig), and GD1b (3 |ig). Lane 4, gangliosides (top to bottom); 
GM3 (3 |xg) and Gl\/12 (3 |Lig). 
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Table 1. Binding of M. hyopneumoniaeXo various lipids and glycolipids 
Lipids Structure binding® 
Neutral SDhinaolioids 
Sphingomyelin -
Cerebroside Gal-B1-1Cer -
Sulfatide Gal(3S04)B1-1Cer ++ 
Lactosyl ceramide GalB1-4Glc1-1Cer -
Ceramide trihexoside Gala1-4GalR1-4Glc1-1Cer -
Globoside GalNAcBI -3Gala1 -4GalB1 -4Glc1 -1 Cer + 
Ganqliosides 
GM1 Gal(31 -3GalN AcR1 -4[NeuAca2-3]GalB1 -4Glc(31 -1 Cer -
GM2 GalNAcBI -4[NeuAc(x2-3]GalB1 -4Glc61 -1 Cer -
GM3 NeuAca2-3GalB1 -4GlcB1 -1 Cer ++ 
GD1a NeuAca2-3GalB1-3GalNAcB1-4[NeuAca2-3]Gal61-4GlcB1-1Cer -
GD1b GalB1-3GalNAc(31-4[NeuAca2-8NeuAca2-3]Gal61-4Glc61-1Cer -
GD3 NeuAca2-8NeuAca2-3GalB1 -4GlcB1 -1 Cer -
GT1b NeuAca2-3 GalB1-3GalNAc81-4[NeuAca2-8NeuAca2-3]GalB1-
4GlcB1-1Cer -
Asialo-GM1 GalB1 -3GalN AcB1 -4GalB1 -4GlcB1 -1 Cer -
Non-Dolar lioids 
Cholesteryl palmitate -
Tripalmitin -
Palmitic acid -
Cholesterol -
Cholesterol sulfate -
® (-) No binding to 5 jag of lipid; (+) positive binding to 3 jug of lipid; (++) positive binding to less than 0.5 
^g of lipid. 
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Binding of mycoplasmas to lipids extracted from porcine cilia. A 
variety of lipids were extracted from swine cilia. Many of them were detected by 
using Bial's reagent and therefore regarded as giycolipids. Three of them (La, Lb, 
and Lc) were bound by M. hyopneumoniae in the TLC overlay assay (Fig. 2). Lc 
had a mobility similar to that of sulfatide, but was barely detectable with Bial's 
reagent (Panel A of Fig. 2). Binding of mycoplasmas to Lc was stronger than to La 
and Lb. After Folch partition, Lc along with another lipid (Ld) was distributed to the 
upper phase, whereas most of the other ciliary lipids were retained in the lower 
phase (Fig. 2). Lc was also not detected by 2,7-dichlorofiuorescein, which detects 
both saturated and nonsaturated lipids. Ld was detected as a dense band by Bial's 
reagent and had a mobility similar to that of ganglioside GM2. M. hyopneumoniae 
did not bind to Ld (Fig. 2). 
Binding of M. hyopneumoniae to purified receptors in microtiter 
plates. La, Lb, Lc, and Ld were purified to homogeneity from the TLC 
chromatograms. On TLC plates, preparations of La, Lb, and Ld were detected as 
single bands by the Bial's reagent; no band was detected with Bial's reagent in the 
preparation of Lc (data not shown). Purified La, Lb, and Lc still bound M. 
hyopneumoniae in the TLC overlay assay (not shown). This specific binding was 
further confirmed in microtiter plates in which sensitive and dose-dependent 
binding of mycoplasmas was detected with immobilized sulfatide, Lc, La, and Lb 
(Fig. 3). No significant binding was detected to immobilized Ld, glucocerebroside, 
and the auxiliary lipids. 
Fig. 2. Binding of M. hyopneumoniae to ciliary giycolipids on TLC plates. Panel 
A, sprayed with Bial's reagent. Panel B, overlaid with M. hyopneumoniae. 
Lane 1, sulfatide (2.5 |j,g). Lane 2, total lipid extract of cilia from 5 mg wet 
cilia (5 |il). Lane 3, lower phase of Folch partition of ciliary lipids from 10 
mg wet cilia. Lane 4, upper phase of Folch partition of ciliary lipids from 
10 mg wet cilia. 
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Fig. 3. Binding of M. hyopneumoniae to immobilized glycolipids in microtiter 
plates. La, Lb, Lc, and Ld purified from 50 mg wet cilia were diluted to 
1:640, 1:320, 1:160, 1:80, 1:40, and 1:20 in methanol, and sulfatide 
was diluted to 0.025, 0.5,1.0, 2.0, 4.0, and 8.0 |ig per ml for coating 
the microtiter plates as described in the Materials and Methods. M. 
hyopneumoniae (2 x 108 CCU per well) was added and incubated for 
90 min at 37 °C. Bars represent mean OD ± SD of 4 wells from three 
experiments. 
Binding of laminin to ciliary lipids. To characterize tine chemical nature 
of the ciliary receptors, ciliary lipids along with standard glycolipids were also 
overlaid with laminin, a glycolipid which specifically binds to sulfated glycolipids 
but not to non-suifated glycolipids. As expected, laminin bound to sulfatide, but not 
to gangliosides and neutral glycosphingolipids (Fig. 4). Laminin also bound to 
three ciliary glycolipids, La, Lb, and Lc (Fig. 4), which were receptors for M. 
hyopneumoniae. No binding of laminin was detected to other ciliary lipids (Fig. 4). 
Adherence activity of llpld-extracted cilia. In order to elucidate the 
significance of ciliary glycoproteins in the adherence of M. hyopneumoniae, the 
proteinaceous precipitate of cilia, derived from choloroform-methanol extraction, 
was immobilized to microtiter plates to test for the binding of mycoplasmas. Lipid-
extracted cilia still had adherence activity to the mycoplasma, but the activity was 
substantially lower than that obtained with nonextracted cilia (Fig. 5). 
Discussion 
TLC overlay assay has been widely used for characterization of glycolipid 
receptors for microbial pathogens (12,14). An advantage of the assay is that TLC 
plates present glycolipid receptors in a conformation similar to that of the eucaryotic 
cell membrane (12). In this study, M. hyopneumoniae selectively attached to 
several glycolipid standards, including sulfatide, ganglioside GM3, and globoside 
(Fig. 1). The specific carbohydrate sequence responsible for binding of /W. 
Fig. 4. Binding of laminin to standard glycolipids and ciliary lipids on TLC plates. 
Panel A, sprayed with Bial's reagent. Panel B, overlaid with laminin. Lane 
1, neutral glycosphingolipids in order of their migration: cerebroside (C, 3 
|ng), lactosylceramide (L, 3 |ig), ceramidetrihexoside (T, 3 |ig) and 
globoside (G, 3 |ig). Lane 2, sulfatide (2.5 |ig). Lane 3, total lipid extract of 
5 mg wet cilia. Lane 4, gangliosides in order of their migration (top to 
bottom): Asialo-GM1 (3|ig), GM1 (3 |ig), and GD1a (3 fig). 
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Fig. 5. Binding of M. hyopneumoniae to immobilized whole cilia, lipid-
extracted cilia, and gelatin in microtiter plates. Results were presented 
as mean OD ± SD (n=8). 
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hyopneumoniae was not identified in the glycolipids. M. pneumoniae, a human 
pathogen, bound to glycolipids containing the terminal Gal(3S04)pi- residue (16). 
Many pulmonary pathogens were shown to have a binding specificity for the 
GalNAcpi-4Gal sequence in glycolipids (15). The binding of M. hyopneumoniae to 
diverse carbohydrate sequences in glycolipids suggests that there might be 
several different receptors existing in cilia. Binding of the mycoplasma to 
ganglioside GM3 was unexpected because sialic acid did not inhibit adherence of 
M. hyopneumoniae, and treatment of cilia with neuraminidase did not affect the 
binding of this organism in a previous study (28). 
Three ciliary receptors (La, Lb, and Lc) for M. hyopneumoniae were 
identified with the TLC overlay assay (Fig. 2). Their receptor specificity was further 
confirmed by mycoplasmal binding to purified individual receptors immobilized on 
microtiter plates (Fig. 3). All three lipids were believed to be glycolipids because 
they yielded a positive reaction with Bial's reagent (except for Lc) and were bound 
by laminin. Lc had a mobility similar to that of sulfatide on TLC plates, but it was not 
detected by either Bial's reagent or 2,7-dichlorofluorescein. Further analysis using 
NMR, MS, GLC, or other biochemical means will provide more information on the 
chemical nature of Lc. Folch partition separates total lipids into two phases (9,11); 
the upper phase usually contains hydrophilic glycolipids, and the lower phase 
contains phospholipids, glycolipids, and neutral lipids (11). Because Lc was 
retained in the upper phase and was also bound by laminin, it was believed that Lc 
was a hydrophilic sulfated glycolipid. The reason that Lc was not detected by 
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orcinol ferric chloride and 2,7-dichlorofluorescein is unknown. Lc might be a minor 
lipid in the membrane of cilia, and therefore not easily detectable by using the 
spray reagents. The strong binding by M. hyopneumoniae indicated that Lc might 
be a high-affinity receptor for the mycoplasma. It is unlikely that the three glycolipid 
receptors are gangliosides because they have different mobilities from those of 
standard gangliosides on TLC plates. Ld had a mobility similar to that of GM2, but 
was not bound by M. hyopneumoniae, suggesting that ciliary gangliosides were 
not involved in the adherence although M. hyopneumoniae bound to GMS in the 
TLC overlay assay. 
Because similar carbohydrate sequences may exist in both glycolipids and 
glycoproteins, results from this study did not exclude the possibility that some ciliary 
glycoproteins are also involved in attachment of M. hyopneumoniae. Two types of 
receptors, sialylglycoproteins (22) and sulfated glycolipids (16), were identified for 
M. pneumoniae. As shown in Fig. 5, lipid-extracted cilia had substantially lower 
adherence activity. The remaining adherence activity could be attributable to lipid 
residues or proteinaceous receptors in the extracted cilia. No matter what the 
source of the remaining adherence activity is, it can be concluded that ciliary 
glycoprotein (s) was not the major receptor (s) for the mycoplasma. 
Laminin is a major basement membrane glycoprotein that participates in cell 
growth, differentiation and migration (23). In a previous study, we found that laminin 
inhibited adherence of M. hyopneumoniae to a ciliary extract by interacting with 
some components in cilia (28). In this study, laminin bound to La, Lb, and Lc which 
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were receptors for the mycoplasma. This result provided an explanation for the 
adherence-interfering mechanisms of laminin. This glycoprotein has a binding 
specificity to sulfated glycolipids and has been used to identify these lipids (23). 
Binding by laminin of the three ciliary receptors for M. hyopneumoniae indicated 
that they are sulfated glycolipids in nature. This finding was correlated with the 
results obtained in a previous study (28) in which several sulfated receptor 
analogues inhibited adherence of M. hyopneumoniae Xo single ciliated cells and to 
purified cilia immobilized onto microtiter plates. Several species of mycoplasmas 
other than M. hyopneumoniae also utilized sulfated glycolipids as receptors (16, 
17). 
The mechanism by which M. hyopneumoniae damages ciliated cells is not 
known. No toxins have been reported for the mycoplasma. DeBey (4) 
demonstrated that direct contact of M. hyopneumoniae with ciliated cells was 
required for production of cytotoxicity, by separating mycoplasmas from ciliated 
epithelium with a 0.1 \xm membrane. Therefore, it is possible that the adhesin (s) of 
M. hyopneumoniae not only mediates mucosal adherence but also induces 
pathogenic effects on ciliated cells by unknown means. Enteropathogenic E. coii 
adhere to the intestinal mucosa and cause effacement of microvilli and 
rearrangement of cytoskeletons in epithelial cells (7). Attachment of 
enteropathogenic E. coli resulted in elevation of intracellular calcium concentration 
and protein phosphorylation, indicating that the effacing lesion resulted from a 
subversion of host cell signal transduction by E. coli attachment (3, 7). Some 
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pathogens, such as Bordetella pertussis and Yersinia spp., utilize integrins, a 
family of glycoproteins involved in cell-cell and cell-extracellular matrix recognition, 
as receptors (13). Binding of the pathogens to integrins triggered signal 
transduction in host cells and change of cell functions (3). It is not known if M. 
hyopneumoniae can trigger signal transduction in ciliated cells by ligand-receptor 
mediated adherence. DeBey et al. (5) reported that M. hyopneumoniae infection 
enhanced the level of cytosolic calcium in neutrophils. However, no information 
pertaining to the change in ciliated cells was available. Analysis of the structures 
and functions of the ciliary receptors may help to provide more information about 
the pathogenic mechanisms of M. hyopneumoniae. 
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IDENTIFICATION AND CHARACTERIZATION OF MYCOPLASMA 
HYOPNEUMONIAE ADHESINS 
A paper to be submitted to Infection and Immunity 
Qijing Zhang, Theresa F. Young, and R. F. Ross 
Abstract 
A major adhesin of Mycoplasma hyopneumoniae was identified and 
characterized in this study. A monoclonal antibody (Mab) F2G5 and its F(ab')2 
fragments inhibited the adherence of M. hyopneumoniae to porcine cilia, the 
natural targets to which the mycoplasma binds during infection. Mab F2G5 
detected multiple bands, but predominantly recognized a 97 KDa (P97) protein of 
M. hyopneumoniae on immunoblots. Immunolabelling of mycoplasmas with Mab 
F2G5 under electron microscopy demonstrated that the proteins recognized by 
Mab F2G5 were located at the surface of the mycoplasma, predominantly on a 
surface fuzzy layer. Affinity chromatography, conducted with immobilized Mab 
F2G5, purified mainly P97 and a set of minor proteins with distinct sizes. The 
purified proteins were able to bind to cilia and blocked the adherence of intact M. 
hyopneumoniae cells to cilia. Surface proteolysis of M. hyopneumoniae with 
trypsin degraded P97 and decreased the adherence activity of the mycoplasma. 
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The predominant proteins detected by IVlab F2G5 were P97 in strains LI27, 232 
2A3 and 232 FA1, a 95 KDa protein in strain J, and a doublet (93 KDa and 92 KDa) 
in strain 144L, indicating that the antigens bearing the epitope for Mab F2G5 
undergo intraspecies size variation. This variation appeared to be related to the 
adherence capability of M. hyopneumoniae because strains J and 144L had 
substantially lower and higher adherence activity, respectively, than the other 
strains. Intrastrain size variation of adhesins was manifested as ladders of proteins 
on immunobiots stained with Mab F2G5 and as periodic structures produced by 
digestion of purified adhesins with trypsin. These results indicate that P97 is a 
major adhesin of M. hyopneumoniae, which undergoes intraspecies and intrastrain 
size variations. Size variation of adhesins may be a pathogenic mechanism utilized 
by M. hyopneumoniae to evade the porcine immune system. 
Introduction 
Mycoplasma hyopneumoniae is the etiological agent of mycoplasmal 
pneumonia of swine (MPS), an economically important swine disease. It has been 
known that /W. hyopneumoniae colonizes the respiratory epithelium of swine and 
produces a chronic pneumonia in pigs (23). During in vivo infection, the 
mycoplasmas are intimately associated with cilia of ciliated cells and cause an 
extensive loss of cilia as observed under an electron microscope (3, 18, 25). There 
is a general notion that adherence of /W. hyopneumoniae to porcine respiratory 
ciliated cells is a prerequisite for colonization of the organism on the respiratory 
epithelium and development of pneumonia. Previous studies have shown that the 
adherence process is mainly mediated by receptor-ligand interactions (40, 43, 44). 
Several carbohydrates inhibited the adherence of the mycoplasma to cilia in a 
microtiter plate adherence assay, indicating that the receptors in cilia were 
giycoconjugate in nature (40). A subsequent study by use of a thin-layer 
chromatography overlay assay identified three ciliary glycolipid receptors for M. 
hyopneumoniae in porcine ciliated cells (41). 
Virulence factors of M. hyopneumoniae have not been well defined. Several 
proteins of M. hyopneumoniae, including a 36 KDa lactate dehydrogenase (11), 
membrane lipoproteins (30), and a 54 KDa cytotoxic factor (10), have been 
characterized by different research groups: however, the biological functions of 
these proteins in the disease process have not been determined. The adhesin(s) of 
M. hyopneumoniae has not been identified. Previous studies showed that 
treatment of M. hyopneumoniae with trypsin decreased the adherence to single 
ciliated cells and cell monolayers, indicating that the adhesin(s) of M. 
hyopneumoniae might be a trypsin-sensitive protein (43, 44). Identification and 
characterization of M. hyopneumoniae adhesins will improve our understanding of 
the pathogenic mechanisms utilized by the organism and may lead to the 
development of highly efficient measures for control of MPS. In this study, 
monoclonal antibodies, affinity chromatography, surface proteolysis, electron 
microscopy and amino acid analysis were utilized along with an in vitro adherence 
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assay to elucidate the adhesins of M. hyopneumoniae. 
Materials and Methods 
Mycoplasmas and culture conditions. Mycoplasma hyopneumoniae 
strain Li27 was originally derived from an experimentally infected pig. Strains 232 
2A3 and 232 FA1 were cloned from strain 232. Strain J was originally obtained 
from the American Type Culture Collection and maintained in Friis mycoplasmal 
medium (9) in this laboratory. Strain 144L SCI 3AF was isolated in the laboratory 
from the lung of an infected pig and filter-cloned three times. It was known that 
strains LI27, 232 and 144L were pathogenic for pigs, whereas strain J was 
nonvirulent (42). In this study, mycoplasmas were grown in Friis mycoplasmal 
medium supplemented with 20% acid-adjusted swine serum. The cultures were 
incubated in a water-bath shaker at 37°C for 24 to 48 h. The number of 
mycoplasmas was estimated by the determination of color changing units (CCU). 
Mycoplasmas were harvested by centrifugation at 25,000 x grfor 15 min for 
adherence and adherence inhibition assays, the mycoplasmal pellets were 
resuspended to 1/10 of the original volume and further diluted with adherence 
buffer (RPMI 1640 containing 1% gelatin) to the appropriate CCU. For production of 
mycoplasmal proteins required for affinity chromatography, the pellets were further 
washed three times with phosphate-buffered saline (PBS, pH 7.2) and 
resuspended in PBS to 1/100 of the original volume. 
Monoclonal antibodies and fragmentation. Monoclonal antibodies 
(Mab) to various antigens of M. hyopneumoniae were supplied by Barbara 
Erickson (Veterinary Medical Research Institute, Iowa State University, Ames). For 
adherence inhibition, these Mabs in cell culture supernates were concentrated 
about 12 times with ammonium sulfate. Mab F2G5, which inhibited the adherence 
of M. hyopneumoniae to porcine cilia, was purified from ascites with the 
ImmunoPure® IgM purification kit (Pierce, Rockford, IL). Purification was conducted 
according to the instructions supplied with the kit. The purified Mab F2G5 was 
resuspended in PBS and stored at -20°C for affinity chromatography and 
fragmentation. Fragmentation of Mab F2G5 was performed with immobilized 
pepsin as described (2). This digestion method mainly generates F(ab')2 fragments 
from mouse IgM; essentially no (Fc)5^can be produced (2). Briefly, 2 mg of Mab 
F2G5 was applied to a Centricon™ 100 microconcentrator (Amicon, Danvers, MA) 
and spun down at 4,000 gior 40 min at 4°C. The retentate containing the Mab was 
washed twice with IgM F(ab')2 digestion buffer (10 mM sodium acetate, 150 mM 
NaCI, 0.05% NaNa, pH 4.5) and finally resuspended in 1 ml digestion buffer. A 
small column packed with 2 ml pepsin-agarose (Pierce, Rockford, IL.) was 
equilibrated with 10 ml of the digestion buffer and prewarmed at 37°C for 5 min. 
One ml of Mab F2G5 was added to the column and incubated at 37°C for 2 h. The 
digest was eluted with 4 ml of the digestion buffer. The eluate was filtered with a 
Microsep™ 300 concentrator to remove nondigested IgM. The filtrate was further 
concentrated with a Centricon™ 30 microconcentrator. The retentate, mainly 
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containing F(ab')2 fragnnents, was waslied twice witfi PBS and resuspended in 0.5 
ml PBS. F(ab')2 fragments of Mab 80.1, an antibody against a 64 KDa protein which 
did not inhibit the adherence of M. hyopneumoniae to porcine cilia, were prepared 
using a similar procedure. 
Adherence and adherence inhibition. A microtiter plate adherence 
assay (MPAA) was conducted as described previously (40). Briefly, M. 
hyopneumoniae whole cells (2 x 108 CCU) or mycoplasmal proteins (10 iig/ml) 
resuspended in adherence buffer were added into microtiter plates coated with 
SDS-solubilized porcine tracheal cilia and incubated at 37°C for 90 min. The non-
attached mycoplasmas or proteins were washed off the plates with PBS. The 
mycoplasmas or mycoplasmal proteins attached to the plates were detected by 
sequential addition of rabbit anti-/W. hyopneumoniae hyperimmune antibodies and 
goat anti-rabbit immunoglobulins conjugated with peroxidase. ABTS was finally 
added, and the optical density (OD) at 405 nm was measured. For inhibition 
assays, various Mabs or F(ab')2 fragments were preincubated with intact 
mycoplasmas at 37°C for 60 min. Two washings with PBS were conducted to 
remove unbound antibodies. The preincubated mycoplasmas were added into 
cilia-coated plates, and adherence was measured as described above. Percentage 
of inhibition was calculated as described previously (40). Adhesins purified by Mab 
F2G5 affinity chromatography were evaluated for inhibition of the adherence of 
intact mycoplasmal cells. For this purpose, cilia-coated wells of microtiter plates 
were first incubated with the purified adhesin at 37°C for 90 min. The adherence 
96 
buffer was utilized as the nonlnhibitory control. After 4 washings with PBS, intact M. 
hyopneumoniae cells were added to the wells and incubated at 37°C for 90 min. 
Four washings with PBS were performed to remove non-attached mycoplasmas. 
The attached mycoplasmas were sequentially detected with a monospecific rabbit 
antiserum (R409) against a 64 KDa surface protein of M. hyopneumoniae (39) and 
goat anti-rabbit immunoglobulin conjugated with peroxidase. It was determined in 
a preliminary experiment that antiserum R409 did not cross-react with the purified 
adhesins, but reacted with whole cells of the mycoplasmas. 
Surface proteolysis of mycoplasmas with enzymes. Proteolytic 
digestion of intact mycoplasmas was performed as described previously (8). M. 
hyopneumoniae strain LI27 grown in Friis mycoplasmal medium was harvested 
and washed three times with PBS by centrifugation. The mycoplasmas were 
resuspended to 0.5 mg/ml (protein concentration) in PBS. One ml of mycoplasmas 
was incubated with various doses (final concentrations: 0, 0.01, 0.04, 0.1, 0.25,1, 
5, 25, and 100 |ag/ml) of trypsin (type XI, DPCC treated, Sigma Chemical Company, 
St. Louis, MO) at 37°C for 30 min. After digestion, trypsin inhibitor (type l-S, Sigma) 
was added to the mixture at a final concentration of 200 |ig/ml to stop the reaction. 
The treated mycoplasmas were washed three times in PBS and resuspended in 
0.2 ml PBS. Each treated sample was titrated for CCD to determine the viability of 
treated mycoplasmas, evaluated for adherence activity by use of the MPAA, and 
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and immunoblotting with Mab F2G5. Mycoplasmas were also treated with 
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various doses (see Fig. 3.3) of carboxypeptidase Y under similar conditions. The 
treated mycoplasmas were analyzed by SDS-PAGE and immunoblotting. 
Immunoelectron microscopy. Immunolabelling of mycoplasmas with 
Mabs was performed as described previously (1). Briefly, M. hyopneumoniae cells 
resuspended in PBS containing 1% gelatin were incubated with 1:10 diluted Mab 
F2G5 at 37°C for 1 h. Mycoplasmas incubated with cell culture medium were 
utilized as negative controls. The mycoplasmas were washed 3 times with PBS 
and then reacted with 1:10 diluted goat anti-mouse IgM (|i chain specific) 
conjugated with gold (10 nm, Sigma) at 37°C for 1 h. After three washings with 
PBS, the mycoplasmas were fixed with 3% glutaraldehyde-cacodylate buffer, 
dehydrated in acetone, and embedded in epoxy resin. Thin sections were stained 
with uranyl acetate and lead citrate and observed under a Hitachi H500 electron 
microscope. 
Comparison of different strains for adiierence activities. Various 
strains of M. hyopneumoniae were cultured in Phis mycoplasmal medium, 
harvested by centrifugation, and washed with PBS as described above. The 
protein concentration of each strain was adjusted to 25 [ig/ml for the adherence 
assay. The protein profiles of different strains were analyzed by SDS-PAGE and by 
immunoblotting with Mab F2G5. 
SDS-PAGE and immunoblotting. SDS-PAGE was performed according 
to the method of Laemmli with 10% separating gel and 4% stacking gel (16). 
Mycoplasmas or mycoplasmal proteins were mixed with equal volumes of 
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treatment buffer (0.125 M Tris-HCI, pH 6.8, 4% SDS, 20% glycerol, 10% 2-
mercaptoethanol) and heated at 100°C for 3 min prior to electrophoresis. The 
separated proteins were visualized by staining the gels with Coomassie brilliant 
blue R-250. For immunoblotting, proteins on the gels were transferred to 
nitrocellulose membranes as described by Towbin etal. (26). The membranes 
were blocked with 3% BSA , 0.1% Tween 20 in PBS at 25°C for 60 min with gentle 
shaking. Then, the blots was incubated with 1:100 diluted Mab F2G5 at 25°C for 2 
h. After three washings with PBS containing 0.01% tween 20, the blots were further 
reacted with 1:1000 diluted goat anti-mouse immunoglobulins conjugated with 
peroxidase at 25°C for 2 h. Three washings were performed prior to color 
development with 4-chloro-1-naphthol. 
Antibody affinity chromatograptiy. Mab F2G5 was coupled onto Affi-
Gel®10 (Bio-Rad Laboratories, Melville, New York) according to the instructions 
supplied with the activated support. In brief, 6 mg of purified Mab F2G5 
resuspended in 4.5 ml of coupling buffer (0.1 M HEPES, pH 7.5) was mixed with 3 
ml of Affi-Gel® 10. This mixture was incubated at 4°C for 4 h with gentle shaking. 
Then, 0.5 ml of 1M ethanolamine HCI (pH 8.0) was added and incubated at 4°C for 
1 h to stop the coupling. The gel was alternatively washed with 0.1 M Tris-HCI (pH 
7.5) and the coupling buffer. After packing into a small column, the gel was washed 
sequentially with 20 volumes of 10 mM Tris-HCI and 20 volumes of PBS containing 
40 mM CHAPS (3-[(3-cholamidopropyl)-dimethyllammonio]-1-propane-sulfonate). 
Mycoplasmas resuspended in PBS containing 0.2 mM phenylmethylsulfonyl 
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fluoride (PMSF) were solubilized with 40 mM CHAPS at 4°C for 1 h. The lysate was 
ultracentrifuged at 100,000 x grfor 30 min. The supernate containing solubilized 
mycoplasmal proteins was harvested. Preliminary experiments showed that 
adhesins of M. hyopneumoniae were efficiently solubilized by CHAPS. Three ml of 
the supernate containing 12 mg of mycoplasmal proteins were applied to the 
column and reacted at 4°C overnight. Unbound proteins were washed off the 
column with 50 ml of PBS containing 40 mM CHAPS. The proteins captured by the 
Mab were eluted with 0.1 M glycine-HCI (pH 2.5). The eluate was immediately 
neutralized to pH 7.5 with 1 M Tris and concentrated to 1 ml with a Centricon™ 10. 
The purity of the proteins was determined by SDS-PAGE and immunoblotting; the 
adherence activity of the eluted proteins was evaluated in the MPAA; and the 
purified proteins were also utilized to block the adherence of intact M. 
hyopneumoniae cells as described above. 
Digestion of purified adhesins witli trypsin. The controlled digestion 
of purified adhesins was performed as described previously (21). In brief, the 
adhesins purified by antibody affinity chromatography were digested with various 
concentrations of trypsin (0.08 to 2.0 |j,g per ml) at 37°C for 30 min. The digested 
adhesins were immediately mixed with the treatment buffer and boiled at 100°C for 
3 min. The samples from each digestion were pooled and subjected to SDS-PAGE 
and immunoblotting with Mab F2G5 as described above. 
Protein sequencing and amino acid analysis. The N-terminal 
sequence of P97 was determined as described previously (17). The adhesins 
100 
purified by Mab F2G5-affinity chromatography were further separated by SDS-
PAGE as described above. After electrophoresis was completed, the gel was 
washed three times with the transfer buffer (10 mM 3-(cyclohexylamino)-1-
propanesulfonic acid, 10% methanol, pH 11). The proteins on the gel were 
electroblotted to polyvinylidene difluoride (PVDF) Immobilon-P membrane 
(Millipore) at 50 mA for 60 min. After rinsing with distilled water, the membrane was 
stained with 0.1% Coomassie brilliant blue R-250 for 5 min. Destaining was 
conducted with a solution of 50% methanol and 10% acetic acid. Finally, the PVDF 
membrane was thoroughly washed with distilled water and air-dried. The 
membrane was submitted to the Protein Facility at Iowa State University where P97 
was excised from the membrane and subjected to automatic Edman degradation 
by using an Applied Biosystems 477A liquid-pulse sequencer. For analysis of total 
amino acid compositions, P97 was excised and analyzed with an Applied 
Biosystems 420 PTC amino acid analyzer. 
Results 
Adherence inhibition by l\/labs or Mab fragments. Various Mabs 
were evaluated for ability to inhibit the adherence of M. hyopneumoniae \o porcine 
cilia (Table 1). Two Mabs, F2G5 and F1B6, inhibited up to 67% of the adherence 
(Table 2). A similar result was obtained when the hyperimmune serum used for 
detection was replaced with antiserum R409 (a rabbit monospecific antiserum to a 
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Table 1. Adherence inhibition by various monoclonal antibodies 
Mab Isotype Specificitya Adherence inhibition 
80.1 igM 64 
A1B2 igM 100 
A2H10 igGi 100 
F1B6 IgM Multipieb 
F2B11 lgG2a 86 
F2G5 IgM Muitipieb 
F3A6 lgG2b 116 
F3B8 lgG1 105, 95, 65, 55 
F3D5 lgGi 105, 95, 65, 55 
F3D6 igGi 105, 95, 65, 55 
11D8 igGi 116 
I2E12 IgGi 86 
I2E12 IgGi 86 
I3A6 IgGi 200, 145, 140, 116, 86 
I4A10 IgGi 70 
I4A4 IgGi 100, 90, 80, 60, 50 
I4B1 IgGi 41, 43 
I4B10 IgGi 41 
I4B2 IgGi 41 
I4E3 IgGi 116 
R1E9 igG3 40 
R2E8 IgGi 67 
R3G7 igGi 116 
R4B2 igGi 40 
R4B7 lgG2a 116, 105, 90, 80, 65, 60, 55 
R5F4 IgGi 1 1 6  
R6C10 lgG2a 116, 105, 90, 80, 65, 60, 55 
R6E1 IgGi 116, 40 
R6E4 lgG2a 116, 105, 90, 80, 65, 60, 55 
R6G8 IgGi 46 
- No inhibition was detected with a 12 fold concentrated culture supernate. 
+ Produced dose-dependent inhibition 
a Sizes of antigens (in kilodaltons) detected with strain LI27 on immunobiots: some Mabs detected 
antigens of varied sizes in different strains. 
b Reacted with a set of proteins with distinct sizes, but predominantly recognized a 97 KDa protein. 
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Table 2. Adherence inhibition by monoclonal antibodies F2G5, F1B6 and F3A6 
Dilutiona % inhibitionb produced by Mabs 
F3A6 F1B6 F2G5 
1:2 -11.9 ± 3.1 67.0 + 5.1 66.2 ± 4.5 
1:10 2.5 ± 2.2 45.9 ± 3.4 58.7 ± 5.0 
1:50 -11.1 + 6.5 -10.8 ±6.1 29.5 ± 3.7 
1:250 -1.1 ± 2.4 -9.7 ± 8.0 13.0 ± 4.1 
a Mabs were concentrated approximately 12 times from culture supernate and 
further diluted in the adherence buffer. 
b Mean ± SD of three independent experiments. 
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64 kDa surface protein of the mycoplasma), indicating that the two Mabs indeed 
blocked the adherence of mycoplasmas rather than the detection process. As 
determined by immunoblotting, both Mabs had identical antigenic specificity, 
detected multiple bands, and reacted predominantly with P97 (Fig. 1). Several 
Mabs, such as R6C10,13A6 and F3D5, which also detected mutiple bands on 
immunoblots, did not inhibit the adherence (Table 1). The adherence-inhibiting 
activity was further evaluated with F(ab')2 fragments of F2G5. As compared with the 
adherence buffer which was a negative control, the F(ab')2 fragments of Mab F2G5 
produced 60% inhibition of the adherence of M. hyopneumoniae, while no 
inhibition resulted with the F(ab')2 of Mab 80.1 (data not shown). 
Binding of solubilized mycoplasmal proteins to cilia. Preliminary 
studies showed that CHAPS-solubilized mycoplasmal proteins adhered strongly to 
swine cilia. M. hyopneumoniae proteins solubilized with 40 mM CHAPS were 
ultracentrifuged at 100,000 g for 30 min (at 4°C) to remove nonsolubilized debris. 
The supernate diluted in adherence buffer was directly added to cilium-coated 
plates for adherence assay. Mycoplasmal proteins attached to the plates were 
detected with various Mabs and peroxidase-labelled goat anti-mouse 
immunoglobulins. The attached mycoplasmal proteins reacted only with Mab 
F2G5, but not with Mabs against 41 KDa, 64 KDa, 100 KDa and 116 KDa 
mycoplasmal antigens (Table 3). 
Surface proteolysis of mycoplasmas. Under the conditions used in this 
study, treatment of M. hyopneumoniae with various doses ( 0.01 to 100 [xg per ml) 
Fig. 1. Antigenic specificity of monoclonal antibodies. Total mycoplasmal 
proteins of strain LI27 separated by SDS-PAGE were transferred to a 
nitrocellulose membrane and reacted with Mabs F2G5 (lane 1), F1B6 
(lane 2), and R6C10 (lane 3). Sizes of proteins (in kilodalton) are 
shown on the left. 
1 2  3 
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Table 3. Adherence of solubillzed mycoplasmal proteins to cilia 
Mab Specificity^ OD valueb 
F3A6 116 0.039±0.003 
F2G5 Multiple^ 0.853+0.041 
R6C10 105, 90, 80, 65, 60 0.053±0.006 
80.1 64 0.038±0.009 
I4B2 41 0.010±0.000 
A2H10 100 0.026±0.001 
aSizes of antigens (in kilodaltons) detected in strain LI27. 
b Mean ± SD of triplicate experiments 
cReacted with multiple bands, but predominantly recognized a 97 K protein. 
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of trypsin did not significantly affect the viability of mycoplasmas as determined by 
CCD titration (data not shown). As demonstrated by SDS-PAGE, low 
concentrations (0.01 to 1 |xg/ml) of trypsin selectively degraded three mycoplasmal 
proteins, including P97, PI 05 and P46 (Fig. 2). Immunoblotting of trypsin-treated 
mycoplasmas with Mab F2G5 confirmed that P97 had been gradually digested 
(Fig. 2). Loss of P97 was accompanied by increased yield of P78 and P72 (Fig. 2). 
In fact, the P78 region was not a single protein, but contained a group of proteins 
with sizes ranging from 78 KDa to 82 KDa. P72 and P78 were relatively insensitive 
to trypsin, but they were also gradually digested at 25 to 100 |ig/ml trypsin (data not 
shown). Mycoplasmas treated with 0.001 to 0.2 |ig/ml trypsin had a decreased 
adherence capability, whereas an increased adherence activity was observed with 
mycoplasmas treated with 5 and 25 |ag/ml trypsin (Table 4). However, solubilized 
trypsin-treated mycoplasmas showed a linear decrease in adherence to cilia with 
increased amount of trypsin (data not shown). The changes in protein profiles and 
adherence activities of M. hyopneumoniae caused by trypsin were highly 
reproducible under the conditions of this study. In contrast to trypsin, 
carboxypeptidase Y did not digest P97 from the surface of M hyopneumoniae at 
various concentrations up to 125 |j.g/ml (Fig. 3). 
Strain variation in adherence. Five strains of M. hyopneumoniae 
differed markedly in adherence activity when evaluated using the MPAA (Fig. 4). 
The adherence activity of strain J was substantially lower than for other strains, 
whereas strain 144L had the highest adherence activity among the 5 strains. One 
Fig. 2. Surface proteolysis of intact mycoplasmas. M. hyopneumoniae (LI27) 
cells were treated with graded doses of trypsin: 0.0 |ig/ml (lane 1), 0.01 
|ig/ml (lane 2), 0.04 fig/ml (lane 3), 0.1 |ig/ml (lane 4), 0.25 [ig/ml (lane 
5), 0.5 |ig/ml (lane 6), 1 |ig/ml (lane 7), and 5 ng/ml (lane 8) as described 
in the text. A, SDS-PAGE profile stained with Coomassie brilliant blue. B, 
immunostaining with Mab F2G5. Sizes of proteins (in kilodaltons) are 
shown on the left of each panel. 
1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 
 ^S9 ei iB'fii B a S9 s 0  -  - -  -
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Table 4. Adherence activities of mycoplasmas treated with trypsin 
Concentration 
of trypsin (ixg/ml) 
Adherence (OD value)a 
0.00 0.67±0.01 
0.01 0.48±0.02b 
0.04 0.47±0.02b 
0.10 0.43+0.01 b 
0.25 0.32±0.01b 
0.50 0.43±0.03b 
1.00 0.71±0.01 
5.00 1.25±0.03b 
25.0 0.80±0.02b 
100 0.60±0.02 
a Mean ± SD in triplicate experiments. 
^Significantly different from the non-treated control as determined by an analysis of 
variance with the Tukey contrast (P<0.05). 
Fig. 3. Digestion of mycoplasmas with carboxypeptidase. M. 
hyopneumoniae (LI27) cells were treated with various 
concentrations of carboxypeptidase Y as described in the text: 
lane 1, nontreated control; lane 2, 0.2 |ig/ml; lane 3,1.0 |a.g/ml; 
lane 4, 5 |4.g/ml: lane 5, 25 |j.g/ml; lane 6,125 [xg/ml. Mycoplasmas 
were analyzed by SDS-PAGE and immunoblotted with Mab F2G5. 
Sizes of proteins (in kilodaltons) are shown on the left of each 
panel. 
97-
78-
72" 
36-
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LI27 232 FA1 232 2A3 J25934 144L 
Strain 
Adherence activities of various M. hyopneumoniae strains. 
Mycoplasmas from each strain were adjusted to 25 jig protein/ml and 
evaluated for adherence activity in the MPAA. Bars with different 
letters were significantly different as determined by analysis of 
variance (P<0.01). 
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of the major differences revealed by SDS-PAGE among the five strains was in the 
regions detected by Mab F2G5 (Fig. 5). Several bands including P97 and P46 
were missing in strains J and I44L. P116 was also absent in strain J. Like P97, P46 
was also sensitive to trypsin as show in Fig. 2. Immunoblotting with Mab F2G5 
revealed that P97 was missing in strain 144L and strain J, with the concomitant 
appearance of a 95 KDa protein in strain J and a doublet (93 KDa and 92 KDa) in 
strain 144L that reacted with Mab F2G5 (Fig. 5). Also, P72 was hardly detectable in 
strain J and disappeared in strain 144L, but both strains J and 144L had an extra 
band (approximately 69 KDa) that reacted with the Mab (Fig. 5). 
Immunoelectron microscopy. M. hyopneumoniae cells were reacted 
with F2G5 and goat anti-mouse IgM conjugated with gold particles to determine the 
distribution of the adhesins on mycoplasmas. Mab F2G5 stained the fuzzy surface 
structures of M. hyopneumoniae (Fig. 6). The gold-labeling distributed randomly on 
the surface of mycoplasmas: it was not polarized at a specific region as 
demonstrated with the P1 adhesin of M. pneumoniae. Mycoplasma 
hyopneumoniae cells reacted with cell culture medium and conjugate were utilized 
as a negative control and did not display any labeling with the gold particles (Fig. 
6). 
Affinity chromatography. From 12 mg of starting material, approximately 
150 |ig of protein were purified by Mab F2G5 affinity chromatography. SDS-PAGE 
showed that the predominant protein captured by immobilized F2G5 from LI27 was 
P97 (Fig. 7). Some faint bands were also present below P97. These minor proteins 
Fig. 5. Antigenic heterogeneity among various strains. A, SDS-PAGE protein 
profiles stained with Coomassie brilliant blue. B, immunostaining with 
Mab F2G5. Lane 1, LI27, Lane 2, J. Lane 3, 232 FA1. Lane 4, 232 2A3. 
Lane 5, 144L. Sizes of proteins (in kilodaltons) are shown on the left and 
right of each panel. 
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Fig. 6. Transmission electron micrograph of mycoplamas immunolabelled with 
Mab F2G5 and gold particles. A, mycoplasmas incubated with cell culture 
medium and gold-conjugates as a negative control. B, mycoplasmas 
reacted with Mab F2G5 and gold-conjugates. Arrows indicate the fuzzy 
structures labelled with gold particles. Bars represent 0.1 |im. 

Fig. 7. Purification of adhesins by antibody (Mab F2G5) affinity 
chromatography. Lane 1, total nnycoplasmal proteins (LI27); lane 2, 
eluate from Affi-Gel 10-Mab F2G5 column (1.5 |ig): lane 3, 2 fold 
greater load of the eluate. A, SDS-PAGE profile stained with 
Coomassie brilliant blue. B, immunostaining with Mab F2G5. Sizes of 
proteins (in kilodaltons) are shown on the left and right of each panel. 
1 2 3  1 2  3  
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also reacted with Mab F2G5. On immunoblots, the purified proteins reacted 
specifically with Mab F2G5 (Fig. 7). A ladder of proteins was detected by F2G5 in 
close proximity to P72. These bands had a spacing periodicity of approximately 2 
KDa. Interestingly, Mab F2G5 did not detect P78, but did detect a 81 KDa protein in 
the purified materials (Fig. 7). The purified proteins adhered strongly to cilium-
coated wells, but not to control wells coated with gelatin or albumin in the microtiter 
plate adherence assay (Fig. 8). The purified proteins also produced a dose-
dependent inhibition of the adherence of intact M. hyopneumoniae cells to cilia 
(Table 5). 
Size variation. Since Mab F2G5 reacted with mutipie proteins of M. 
hyopneumoniae from a single strain, the relationship among these proteins 
needed to be determined. One possibility was that these proteins were size 
variants. Size variation of epitope-bearing proteins in mycoplasmas has been 
illustrated by increasing the population of mycoplasmas loaded for SDS-PAGE or 
by treatment of mycoplasmas with proteolytic enzymes (21). In this study, ladders of 
bands were demonstrated with Mab F2G5 when a five to ten fold greater load of 
LI27 was used for SDS-PAGE (Fig. 9). It seemed that there were different sets of 
size variants (brackets in Fig. 9) in a single strain; each one had a predominant 
protein. This reactivity of Mab F2G5 to multiple proteins was unchanged when 
SDS-PAGE was run under nonreducing conditions. Since size-variable antigens 
usually contain repetitive amino acid sequences and display periodic structures 
when treated with trypsin, the purified P97 were also digested with trypsin. This 
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^ Cilium-coated 
^ gelatin-coated 
3.7 7.5 15 30 
Concentration of adhesins (iig/ml) 
Dose-dependent binding of purified adhesins to cilia. The adhesins 
purified by antibody affinity chromatography were diluted in the 
adherence buffer and directly applied to wells of microtiter plates 
coated with solubilized cilia or with gelatin (negative control). 
Attached proteins were detected with hyperimmune antibodies as 
described in the text. Data were expressed as mean OD ± SD of three 
independent experiments. 
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Table 5. Inhibition of M. hyopneumoniae adherence by purified adhesins 
Mycoplasma Adherence^ in the presence of purified adhesins: 
(CCD) 0.0 |ag/ml 8 ixg/ml 30 |ig/ml 60 |ig/ml 
5x 108 0.55+0.03 0.47±0.03 0.37±0.03b 0.24±0.02b 
2x 108 0.40±0.01 0.31±0.02b 0.20±0.02b 0.11±0.01b 
8x 107 0.21±0.01 0.15±0.01b 0.12±0.01b 0.07±0.01b 
a Detected with a monospecific serum (R409) that did not react with P97 and its 
size variants. Data were expressed as mean OD ± SD of duplicate experiments, 
b Significantly different from the noninhibitory controls as determined with analysis 
of variance (P<0.05). 
Fig. 9. Demonstration of F2G5-reacting size-variable antigens. Mycoplasmal 
proteins (LI27) separated by SDS-PAGE were immunostained with 
Mab F2G5. The number of mycoplasmas (CCU) in each of the lanes 
were approximately 1 x 108 (lane 1), 2.5 x 108 (lane 2), 5 x 108 (lane 
3), and 1 x 109 (lane 4). Sizes of proteins (in kilodaltons) are 
indicated on the left. The brackets indicate ladders of proteins 
recognized by Mab F2G5. 
(O 
CO 
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treatment yielded a ladder of peptides that reacted with F2G5 (Fig. 10). The 
minimum resolvable fragment of trypsin-digested adhesins was approximately 20.5 
KDa. The size difference between the peptides was the multiple of 0.5 KDa. 
N-terminal sequence and amino acid composition. Expressed in 
single-letter code, the N-terminal sequence of P97 beginning with alanine was 
ADXKTDSDKDPSTLRAIDEQ. The X in position 3 indicated an ambiguous residue. 
This sequence was compared by GCG with all known protein and DNA sequences 
in GenBank, EMBL and Swiss-Prot. No homology was detected between 
thissequence and the sequences of known bacterial or mycoplasmal adhesins. 
Analysis with Peptidestructure in the GCG sequence analysis software package 
predicted that the N-terminus of P97 was hydrophilic and surface-exposed (data 
not shown). The total amino acid composition of P97 was also determined, 
showing that there was no cysteine in P97 (Table 6). 
Discussion 
It was found in this study that Mab F2G5, which recognized a predominant 
97 KDa protein in several strains of M. hyopneumoniae, and its F(ab')2 fragments 
inhibited the adherence of M. hyopneumoniae \o cilia (Table 2); purified P97 and 
its size variants adhered to cilia and blocked the adherence of intact M. 
hyopneumoniae cells (Fig. 8 and Table 5); treatment of mycoplasmas with trypsin 
degraded P97 and decreased adherence of M. hyopneumoniae (Fig. 3.2 and 
Fig. 10. Proteolysis of purified adhesins. Tine adhesins purified by antibody 
affinity chromatography were digested with graded doses of trypsin 
(0.08, 0.2, 0.5, and 2.0 |ig/ml) as described in the text. Samples were 
pooled, separated by SDS-PAGE, and immunoblotted with Mab 
F2G5. Lane 1, mixture of digested adhesins (6 |ig): lane 2, 
nondigested adhesins (3 |j.g). Sizes of proteins (in kilodaltons) are 
indicated on the right. 
_1 2 
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Table 6. Amino acid composition of P97 
Amino acid Composition (Mol%) 
Asp 17.46 
Glu 16.28 
Ser 6.18 
Gly 5.71 
His 0.77 
Arg 1.85 
Thr 4.54 
Ala 8.70 
Pro 4.10 
Tyr 2.94 
Val 3.25 
Met 0.31 
lie 4.02 
Leu 8.71 
Phe 4.29 
Lys 10.92 
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Table 4); and immunoelectron microscopy demonstrated that Mab F2G5-reacting 
proteins were located on the surface of M. hyopneumoniae (Fig. 6). Based on these 
findings, it can be concluded that P97 is a major adhesin of M. hyopneumoniae. 
Previous studies indicated that P97 was expressed during in vivo infection 
and was one of the major immunogens of M. hyopneumoniae (37, 38). In fact, P97 
elicited a very early immune response in the respiratory tract of swine because IgA 
and IgM antibodies to P97 were detected in the air way washings of contact-
exposed pigs 35 to 60 days earlier than to other major immunogens of the 
mycoplasma (38). Since P97 was only expressed by virulent M. hyopneumoniae 
and not by nonvirulent mycoplasmas, it had been proposed that P97 might be one 
of the virulence-associated antigens of /W. hyopneumoniae, although the biological 
function of P97 was unknown at that time (37). Results from this study provided new 
evidence for the biological function of P97 in M. hyopneumoniae infection. These 
findings strongly indicate that P97 is an important virulence factor of M. 
hyopneumoniae. 
Sensitivity of P97 to surface proteolysis with trypsin confirmed the 
localization of the protein on the surface of the mycoplasma, as demonstrated with 
immunoelectron microscopy. Mab F2G5 mainly stained the fuzzy structures on the 
mycoplasmas, suggesting that the fuzzy structures may be involved in the 
adherence of the mycoplasmas. It was reported previously that the fuzz on M. 
hyopneumoniae bridges the interaction between mycoplasmas and cilia (3, 25), 
and that the fuzzy structures were only observed with a pathogenic strain but not 
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with a strain that was nonadherent and nonpathogenic in pigs. This evidence, 
together with the information generated from this study, strongly suggested that the 
fuzzy structures on M. hyopneumoniae play an important role in adherence. The 
fuzz on the surface of streptococci, composed of M proteins and lipoteichoic acid, is 
known to mediate the adherence of streptococci to eucaryotic cells (6, 7, 27). 
It is unlikely that the reactivity of Mab F2G5 to multiple proteins was caused 
by the impurity of the Mab. The hybridoma cell line that secretes Mab F2G5 was 
subcioned according to standard procedures, and the secreted antibodies were 
detected as a homogenous IgM isotype. Also, Mab F1B6 which was produced by 
an independent hybridoma had identical antigenic specificity as F2G5. It is also 
unlikely that the multiple reactivity was caused by the degradation of P97 during 
the process of harvesting or SDS-PAGE, because inclusion of a proteinase 
inhibitor (PMSF) during the process did not change the reacting patterns of Mab 
F2G5. It is believed that the reactivity of Mab F2G5 to multiple proteins was indeed 
due to the presence of the epitope in multiple antigens. In fact, the expression of an 
epitope on multiple proteins is very common to many mycoplasmas, including M. 
hyorhinis (21, 22), M. pulmonis (31), M hominis (19), Ureaplasma urealyticum (30), 
and M fermentans (34). 
In this study, we found that Mab F2G5 reacted with ladders of bands on 
immunoblots (Fig. 9) and recognized a different predominant protein in different 
strains (Fig. 5). Treatment of purified P97 yielded periodic peptides (Fig. 10). These 
results suggested that M. hyopneumoniae proteins reacted with Mab F2G5 
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undergo both intraspecies and intrastrain size variation. P97 was a major size 
variant with adherence activity. Since the population of the mycoplasmas was 
rather heterogenous, isogenic populations of M. hyopneumoniae derived from 
single clones will be required to thoroughly determine the size variation and its 
effect on adherence activity of M. hyopneumoniae. 
The P1 adhesin of M. pneumoniae was sensitive to trypsin, while the P30 
adhesin of M. pneumoniae and the MgPa adhesin of M. genitalium were resistant 
to trypsin (20). Treatment of M pneumoniae with trypsin removed two surface 
proteins (P1 and P2) and diminished the adherence of M. pneumoniae to human 
respiratory epithelium (14, 15); regeneration of PI led to the recovery of the 
adherence activity (14). P97, PI 05, and P46 were three M. hyopneumoniae 
proteins that were extremely sensitive to surface proteolysis with trypsin (Fig. 2), 
suggesting that they must be surface-exposed. Besides reactivity with Mab F2G5, 
PI 05 also reacted with several other Mabs that did not inhibit the adherence of M. 
hyopneumoniae to cilia (Table 1). P46 was absent in strain J which is a low-
adherent and nonpathogenic strain. However, P46 was also missing in strain 144L 
which is high-adherent and pathogenic in pigs (Fig. 5). A monoclonal antibody to 
P46 did not inhibit the adherence of M hyopneumoniae (Table 1). The functions of 
P46 and PI05 remain to be defined in future studies. The decrease of adherence 
produced by trypsin digestion was directly correlated with loss of P97. The 
increased adherence activity of mycoplasmas, which had been treated with 5 and 
25 |ag/ml trypsin and had lost P97, can not presently be explained. The 
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mycoplasmas treated with higher concentrations of trypsin became very sticky and 
hard to disperse, suggesting that the membrane properties of the mycoplasmas 
might have been substantially altered. Therefore, the increased adherence might 
have been due to altered membrane properties rather than to an intrinsic increase 
in adherence ability. This speculation was supported by the adherence results 
obtained with solubilized trypsin-treated mycoplasmas, which displayed a linear 
decrease in adherence to cilia with increased concentration of trypsin. 
Degradation of P97 resulted in an increased quantity of P78 (Fig. 2). The 
region of P78 was not a single protein but contained a set of proteins with only 
slight difference in size. Increased quantity of P72 was also observed following 
digestion of P97. Because mycoplasmas were washed after surface proteolysis, 
P78 and P72 must be membrane-associated. Although higher concentrations of 
trypsin also resulted in gradual digestion of P78 and P72, they were less sensitive 
to trypsin than P97. These results suggested that P97, P78 and P72 reacting with 
mab F2G5 were interrelated in structure. One possibility was that P78 and P72 
were the size variants of P97. P97 might have repetitive amino acid sequences as 
shown with the M protein of Streptococci and the variable lipoproteins (VIps) of M. 
hyorhinis (13, 36). This hypothesis was supported by the production of a ladder of 
peptides from the digestion of purified P97 (Fig. 10). It is known that the genes 
encoding for size-variable proteins, such as M proteins and VIps, usually contain 
repetitive coding sequences, and that gain or loss of the repeats leads to 
expression of size-variable proteins (13, 36). A similar mechanism may operate in 
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P97. Molecular cloning and sequencing of tlie gene for P97 will be required to 
confirm this hypothesis. Interestingly, P81 rather than P78 was detected with Mab 
F2G5 in the eluate obtained from antibody affinity chromatography (Fig 7). The 
cause for this discrepancy is unknown at this stage. 
It is known that different strains of M. hyopneumoniae vary in pathogenicity 
for pigs (42). Strains LI27 and 144L were pathogenic, while strain J was incapable 
of inducing pneumonia in pigs. Also, no mycoplasmas were isolated from lungs of 
pigs inoculated with strain J, indicating that this strain had lost the ability to colonize 
the respiratory epithelium (42). Strains 232 2A3 and 232 FA1 were both 
pathogenic for pigs (38, 42), although the experimental infection with strain 232 
FA1 had a prolonged incubation period and induced only a mild clinical disease 
(38). It was found in this study that strain J had substantially lower adherence 
activity than the other strains, whereas strain 144L had the highest adherence 
activity among the five strains evaluated in this study. As demonstrated in Fig. 5, the 
predominant proteins stained by Mab F2G5 in strains J and 144L differed in size 
from those in other strains. It appeared that the size variation of P97 was related to 
the change in adherence capability. Also, the adherence ability of M. 
hyopneumoniae appeared to be correlated with pathogenicity in pigs. However, 
this interpretation should be made cautiously because these strains may also vary 
in virulence traits other than adherence activity. Isogenic strains with only a 
difference in adherence should be utilized to determine the correlation between 
adherence and virulence of M. hyopneumoniae. 
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Carboxypeptidase cleaves a protein from the C-terminus (12). Resistance of 
P97 to digestion with carboxypeptidase Y suggested that the C-terminus of the 
protein was not accessible to the enzyme, and therefore was not at the external 
surface of M. hyopneumoniae. These results also implied that P97 might be 
anchored in the membrane by the C-terminus, rather than the N-terminus as shown 
with the VIp of M. hyorhinis (36). It is unknown if P97 is a lipoprotein. It appeared 
unlikely because P97 was nonextractable with Triton X-114 (data not shown). And 
also, there was no cysteine in P97 (Table 6), which usually is the site for acylation 
of a bacterial or mycoplasmal protein (35, 24). Although a large number of lipid-
modified proteins were found in mollicutes (32, 35), M. hyopneumoniae only had 4 
lipoproteins with molecular weights ranging from 44 to 65 KDa as demonstrated in 
a previous study (33). Cysteine was also absent in the two M. pneumoniae 
adhesins, PI and P30 (20). These results suggested P97 differs in some features 
from the VIps of M. hyorhinis, but is similar to M protein of streptococci which is not 
acylated and is anchored to the cell wall by the C-terminus (13). 
Several mycoplasmal adhesins, such as PI and P30 of M. pneumoniae, and 
PI 40 of M. genitaiium, share considerable homology at both the protein and DNA 
levels (4, 5, 20). However, the N-terminal sequence of P97 did not have any 
homology with known mycoplasmal adhesins. This result suggested that P97 of M. 
hyopneumoniae might be quite distinct from other mycoplasmal adhesins. 
However, it is premature to make this conclusion because the N-terminal sequence 
obtained from this study represented only a small portion of the amino acid 
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sequence of P97, and the internal sequence was not available for comparison in 
this study. Analysis of the amino acid composition of P97 indicated that there were 
no cysteine and tryptophan in P97 (Table 6). However, this does not mean that P97 
does not contain tryptophan because this residue is easily destroyed at the acid 
hydrolysis step required for amino acid analysis (29). Since asparagine and 
glutamine were deaminated to the corresponding carboxylic acids (Asp and Glu, 
respectively) as a consequence of the acid hydrolysis step (29), Asp and Glu 
(Table 6) represented a mixture of asparagine and aspartic acid and a mixture of 
glutamine and glutamic acid, respectively. It will not be possible to know the 
relative amount of each in the mixtures until the full amino acid sequence of P97 
has been determined. These data will be helpful for cloning and sequencing of the 
gene for P97 in future studies. 
P97 may not represent all of the adhesins of M. hyopneumoniae since mab 
F2G5 did not completely inhibit the adherence, and removal of P97 by trypsin did 
not abolish the adherence of M. hyopneumoniae to cilia. This is not surprising 
since pathogenic bacteria and mycoplasmas usually have more than one adhesin. 
For example, M. pneumoniae has 2 defined adhesins, P1, P30 (20); a recent study 
suggested that another surface protein (P90) was also an adhesin of M. 
pneumoniae (8); Bordetella pertussis possesses 4 potential adhesins: filamentous 
hemagglutinin, pertussis toxin, pertactin and fimbriae (25). These adhesins 
mediate the adherence of B. pertussis either to respiratory ciliated cells or to 
macrophages (25). The interactions between multiple adhesins of an organism and 
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the receptors on host cells provide for increased adherence specificity and 
strength. It is expected that more adhesins, other than those recognized by Mab 
F2G5, of M. hyopneumoniae may be discovered in future studies. 
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GENERAL DISCUSSION 
Mycoplasmas are known to be the smallest self-replicating organisms (109). 
A striking characteristic of these agents is their inability to synthesize typical 
eubacteria! cell walls (110). Although simple in structure, mycoplasmas possess 
complex traits to evade host immune systems and to produce persistent infections 
in humans and animals (143). One of the tactics utilized by mycoplasmas is the firm 
adherence to target cells during infection, which is especially true for those 
mycoplasmas that colonize the epithelial linings of the respiratory and urogenital 
tracts (110), such as M pneumoniae, M. genitalium, M. gallisepticum, and M. 
hyopneumoniae. Because of its importance in infection, adherence of 
mycoplasmas to host cells has recently received widespread interest from 
mycoplasmologists. 
Based on the results obtained from this project, it can be concluded that 1) 
the adherence of M. hyopneumoniae \o porcine ciliated cells is mainly mediated by 
specific receptor-ligand interactions; 2) P97, a size-variable surface protein, is a 
major adhesin of the mycoplasma: and 3) the major ciliary receptors for the 
mycoplasma are glycolipids La, Lb, and Lc. In contrast to a previous finding (159), 
hydrophobic interactions play a minimal role in the microtiter plate adherence 
assay. Sensitivity of P97 to trypsin is consistent with previous findings that 
adherence of M. hyopneumoniae to cell monolayers and single ciliated cells was 
diminished by trypsin (157, 160). However, the hemagglutinins of the mycoplasma 
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were not affected by trypsin (154), indicating that the hemagglutinins are different 
from the P97 adhesin and may represent a different class of adhesins. 
Compared with other known mycoplasmal adhesins, P97 shares similarities 
with the PI and P30 adhesins of M. pneumoniae and the MgPa adhesin of M. 
genitalium in that they are all immunodominant antigens and are devoid of cysteine 
(110). However, the three human mycoplasmal adhesins are clustered at tip 
organelles of the organisms rather than randomly distributed on the surfaces like 
P97. In addition, the N-terminal sequence of P97 is distinct from those of PI, P30 
and MgPa. Since P97 is exposed on the surface of mycoplasmal cells, it must have 
a signal sequence that leads to the translocation of P97 from cytoplasm to cell 
membrane. The first N-terminal amino acid of mature P97 is alanine instead of 
methionine, indicating the existence of a leader (signal sequence) which is cleaved 
and removed during the maturation and translocation of P97. P1 and MgPa 
adhesins are known to have signal sequences of 59 amino acids and 58 amino 
acids, respectively, which are longer than other bacterial signal peptides (110). 
Inhibition of adherence by the receptor analogs and identification of three 
native ciliary glycolipid receptors suggested that the carbohydrate moieties in the 
receptors determine the specificity for mycoplasmal adhesins. These results were 
consistent with previous findings that the carbohydrate structures on eucaryotic 
cells determine the adherence specificities of pathogenic bacteria and 
mycoplasmas (70). The carbohydrate structures in the three glycolipids (La, Lb, 
and Lc) are unknown at present. The only clue was that the polysaccharide chains 
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must be sulfated as confirmed by laminin binding. This finding was correlated with 
the result obtained in the microtiter plate adherence assay in which the identified 
receptor analogs were all sulfated compounds. Lc may be a sulfatide, but further 
analysis is required to confirm this speculation. Since the receptor analogs were 
still relatively large molecular structures, the smallest structural unit for the receptor 
epitope (s) was not established. To solve this puzzle, the basic structural units of 
the receptor analogs may be utilized in future studies to block the adherence. Also, 
analysis of the carbohydrate chains in the ciliary glycolipid receptors, by use of 
various modern analytical techniques, will generate valuable information about the 
essential structures of the receptor moieties. 
In vivo studies (4, 99,140, 156) and an in vitro study (160) have indicated 
that M. hyopneumoniae cells are predominantly associated with cilia of swine 
respiratory tract ciliated cells, suggesting that the receptors for M. hyopneumoniae 
may be polarized at the ciliary membrane. However, results from this project did not 
support this speculation. It was found that M. hyopneumoniae adhered as well to 
cell bodies of ciliated cells as to cilia in the microtiter plate adherence assay. The 
adherence of M. hyopneumoniae to cell bodies was also inhibited by the receptor 
analogs that inhibited the adherence of the mycoplasmas to cilia. In addition, the 
three native glycolipid receptors identified in cilia were also present in the cell 
bodies (data not shown). These results suggested that the receptors for M. 
hyopneumoniae were present in both cilia and cell bodies of ciliated cells, and that 
the polarized adherence to cilia might be caused by other factors. For example, the 
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mode of presentation on cell surfaces and the neighboring molecules may affect 
the accessibility or specificity of receptors for pathogens (70). 
It is known that different strains or passage levels of M. hyopneumoniae 
have varied pathogenicity in pigs (158). This change in pathogenicity seems to be 
correlated with the adherence of the mycoplasma because 1) the adherence 
activity of M. hyopneumoniae decreases with increase of in vitro passage levels; 
and 2) strain J, which is nonpathogenic in pigs, had substantially lower adherence 
activity than other strains evaluated in this study. It is possible that the decreased 
adherence by in vitro passage is due to the loss or change of P97. The variation of 
Mab F2G5-reacting proteins caused by in vitro passage remains to be defined in 
future studies. 
The mechanisms utilized by M. hyopneumoniae to damage cilia are 
unknown. A previous study has indicated that direct contact between mycoplasmas 
and cilia is required for induction of cytotoxicity (28). This implies that the loss of 
cilia may be caused in one of two possible ways. M. hyopneumoniae may have 
membrane-associated toxins; the adhesin-receptor mediated attachment brings the 
toxins close to cilia and produces cytotoxicity. This hypothesis needs to be 
confirmed by attempts to isolate and characterize membrane-associated toxins 
from /W. hyopneumoniae. Alternatively, the binding of M. hyopneumoniae adhesins 
to ciliary receptors may trigger a signal transduction cascade across the ciliary 
membrane, which somehow results in degradation of ciliary structural proteins and 
loss of cilia. This theory is possible considering the effacing of microvilli caused by 
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EPEC adherence to intestinal epithelium (9, 30, 97, 112). This hypothesis for 
adherence-mediated loss of cilia may be verified by use of purified P97 along with 
the established tracheal ring organ culture model (28). Inoculation of P97 into the 
model and evaluation of its effect on ciliary structure and function may provide 
valuable information on the pathogenesis of MPS. 
Unlike M. pneumoniae, M. gallisepticum, and M. genitalium, M. 
hyopneumoniae does not have a specialized attachment organelle. However, M. 
hyopneumoniae has an undefined layer of materials outside the limiting membrane 
(140, 155). Also, fuzzy structures protruding from the surfaces were observed with 
mycoplasmas grown in vivo and in vitro (15,140). The nature of these structures 
has not been clarified. Since they are on the outermost surface of M. 
hyopneumoniae, it is plausible to speculate that they are involved in the interaction 
between mycoplasmas and ciliated cells. Identification of P97 on the fuzzy 
structures of M. hyopneumoniae supports this speculation. Isolation and 
purification of the fuzzy structures will be required to fully understand the chemical 
structure and the biological function of the fuzz. Such experiments may be 
attempted by shearing mycoplasmas by physiological means, followed by 
precipitation of the sheared fuzz with ammonium sulfate. 
Because of the economical importance of MPS, developing highly efficient 
measures for control of the disease has been and still will be the focus of many 
research laboratories. The finding of receptor analogs and adhesins of M. 
hyopneumoniae provided potential candidates for prevention of MPS. The roles of 
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mucin, lieparin, fucoidan, and cliondroitin sulfate in interfering with the infection of 
M. hyopneumoniae need to be evaluated in future studies. As a first step, these 
receptor analogs may be evaluated in the swine tracheal ring culture model (28) for 
blockage of colonization and cytotoxicity of M. hyopneumoniae. The full potential of 
the receptor analogs in prophylaxis of MPS may only be understood by conducting 
in vivo studies. 
Adhesins as vaccines have been proven successful for control of bacterial 
diseases (2, 68,103, 119). It is well known that fimbrial vaccines produced from E. 
coii induce protective immunity to diarrhea in animals and humans (2, 68, 75, 118, 
128). However, immunization of guinea pigs with the PI adhesin of M. pneumoniae 
failed to provide protection to subsequent challenge with virulent M. pneumoniae in 
an experimental model (63, 64). One explanation for the failure was that the 
receptor-recognizing domain of the PI adhesin was not immunogenic (110). The 
imunogenicity of P97 in pigs remains to be evaluated in future studies. P97 purified 
by antibody affinity chromatography may be utilized to immunize pigs and to study 
the immune responses to P97. For production of P97 on a large scale, DNA 
recombinant technology should be exploited. This goal can be achieved by cloning 
and sequencing the gene for P97. Since UGA codon (a stop codon in E. coii) is 
used for tryptophan in mycoplasmas, an optimized expression system will be 
required for production of recombinant P97 in full size. Molecular genetic 
characterization of the gene for P97 will not only facilitate the production of P97 for 
vaccination, but also improve our understanding of the mechanisms involved in the 
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size variation of P97, and therefore shed light on the pathogenic mechanisms 
utilized by M. hyopneumoniae Xo produce infection in pigs. 
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